S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d 
car b o x y met h ylcell ul ose
[ADDRESS_195443] 2 0 1 7
Pr o pert y  of G S K C o ns u mer Healt hcare
C o nfi de ntial
Ma y  n ot be use d, di v ul ge d, p u blis he d or ot her wise discl ose d
wit h o ut t he c o nse nt of G S K
Te m plate Versi o n Effecti ve: [ADDRESS_195444] s.
C o m p o u n d N a m e:  S o di u m -c al ci u m mi x e d p arti al s alt of 
p ol y( m et h yl vi n yl et h er/ m al ei c a ci d) a n d 
c ar b o x y m et h yl c ell ul o s e
U nit e d St at e s ( U S) I n v e sti g ati o n al 
N e w Dr u g (I N D) N u m b er:N/ A
E ur o p e a n Cli ni c al Tri al s D at a b a s e 
( E u dr a C T) N u m b er:N/ A
Ot h er R e g ul at or y A g e n c y I d e ntifi e d 
N u m b er:N/ A
Pr ot o c ol N u m b er:2 0 8 3 9 7
P h a s e:II D oc u m e nt N a m e   
T y p e  V ersi o n  D oc u m e nt I d e ntifi er  Eff ecti v e D at e  
    
R e as o n F or Iss u e   
 
 
 
 
 
 
 
 
 
 
 
 
 [ADDRESS_195445]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 1 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195446] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: 2 2-J u n-2 0 1 7
Pa ge 2 of  6 2S p o n s or i nf or m ati o n
S p o ns or Le g al Re gistere d A d dress Gl a x o S mit h Kli ne Rese arc h & De vel o p me nt 
Li mite d
[ADDRESS_195447] A d dress Gla x o S mit h Kli ne C o ns u mer Healt hcare ( G S K C H)
1 8 4 Li bert y C or ner R oa d,
Warre n, NJ, 0 7 0 5 9
Tel:  D oc u m e nt N a m e   
T y p e  V ersi o n  D oc u m e nt I d e ntifi er  Eff ecti v e D at e  
    
R e as o n F or Iss u e   
 
 
 
 
 
 
 
 
 
 
 
 
 [ADDRESS_195448]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 2 of 6 2P P D
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195449] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: [ADDRESS_195450] 2 0 1 7 N ot a p plica ble ( N/ A)
A me n d me nts i nc or p orate all re visi o ns t o date, i ncl u di n g a me n d me nts ma de at t he re q uest of 
c o u ntr y healt h a ut h orities, i nstituti o nal  re vie w b oar ds/et hics c o m mittees (I R Bs/ E Cs), etc.   D oc u m e nt N a m e   
T y p e  V ersi o n  D oc u m e nt I d e ntifi er  Eff ecti v e D at e  
    
R e as o n F or Iss u e   
 
 
 
 
 
 
 
 
 
 
 
 
 [ADDRESS_195451]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 3 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195452] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: 2 2-J u n-2 0 1 7
Pa ge 4 of  6 2P RI N CI P A L I N V E S TI G A T O R P R O T O C O L A G R E E M E N T P A G E
 I c o nfir m a gree me nt t o c on d uct t he st u d y  in c o m p lia nce with t he pr ot oc ol a n d a n y 
a me n d me nts a n d acc or di n g t o t he c urre nt I C H G C P g ui deli nes.
 I ac k n o wle d ge t hat I a m res p o nsi ble f or o verall st u d y  c o n d uct. I a gree t o pers o nall y 
c o n d uct or s u per vise t he descri be d st u d y.
 I a gree t o e ns ure t hat all ass ociates, c ollea g ues a n d e m pl o yees assist i n g i n t he c o n d uct of 
t he st u d y are i nf or me d a b o ut t heir o bli gati ons. Mec ha nis ms are i n place t o e ns ure site staff 
recei ves all a p pr o priate i nf or mati on t hr o u g h o ut t he st u d y .
 I a gree t o c o n d uct t his st u d y in f ull c o nf or ma nce with t he l a ws a n d re g ulati o ns of t he 
c o u ntr y in w hic h t he researc h is c o n d ucte d a n d t he Declarat i on of Helsi n ki.
I n vesti gat or Na me: Jeffre y L. Mille ma n
I n vesti gat or Q ualificati ons: D D S, M P A
I n vesti gat or Si g nat ure:
Date of Si g nat ure/ A gree me nt:
D D/ M M M/ Y Y Y Y D oc u m e nt N a m e   
T y p e  V ersi o n  D oc u m e nt I d e ntifi er  Eff ecti v e D at e  
    
R e as o n F or Iss u e   
 
 
 
 
 
 
 
 
 
 
 
 
 [ADDRESS_195453]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 4 of 6 2P P D
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195454] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: [ADDRESS_195455] i on/I n dicat i on ........................................................................[ADDRESS_195456] i ons ..........................................................1 9
4. 4. 2 C o ntrace pti o n ....................................................................................1 9
4. 5 Scree n Fail ures ..................................................................................................2 0
4. 6 S p o ns or’s Q ualifie d Me dical Pers o n nel ..............................................................2 1
5 S T U D Y T R E A T M E N T S ..............................................................................................2 1
5. 1 Bli n di n g a n d All ocat i on t o Treat m e nt/ Ra n d o misat i o n........................................[ADDRESS_195457]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 5 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195458] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: [ADDRESS_195459] or y ...................................................................................3 1
7. 1. 3 Well -Fi t Assess me nt, Ka p ur ( Ols ha n M o dificati on) I n de x .................[ADDRESS_195460] Q uesti o n naire ........................................................................3 5
7. 2. 3 De nt ure P h ot o gra p hs at Treat me nt Visits ...........................................3 5
7. 3 S af et y ................................................................................................................3 5
7. 3. 1 Or al  S oft Tiss ue ( O S T) E xa mi nat i on - E de nt ul o us .............................[ADDRESS_195461]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 6 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195462] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: 2 2-J u n-2 0 1 7
Pa ge 7 of  6 28. 3. 3 S p o ns or’s Re p orti n g Re q uire me nts t o Re g ulat or y  A ut h orities a n d 
Et hics C o m mit t e es .............................................................................[ADDRESS_195463] i ons .......................................4 4
8. 8. 3 F o ll ow- u p of  Me dical De vice I nci de nts..............................................4 5
8. 8. 4 Re g ulat or y  a n d Et hics Re p orti n g Re q uire me nts f or I nci de nts .............4 6
9 D A T A M A N A G E M E N T ..............................................................................................4 6
9. 1 S o urc e D oc u me nts/ Data ....................................................................................4 6
9. 2 Case Re p ort F or m ..............................................................................................4 6
9. 3 Data Ha n dli n g ....................................................................................................4 7
9. 3. 1 Q ueri es ..............................................................................................4 7
9. 4 Pr ocessi n g Patie nt Re p orte d O utc o mes ..............................................................4 7
9. 5 E xter nal Data .....................................................................................................4 8
1 0 S T A TI S TI C A L C O N SI D E R A TI O N S A N D D A T A A N A L Y S E S ................................. 4 8
1 0. 1 S a m ple Si ze Deter mi nat i on ................................................................................4 8
1 0. 2 Stati stical Met h o ds a n d A nal ytical Pla n .............................................................4 8
1 0. 2. 1 Defi nit i on o f A nal ysis P o p ulat i ons .....................................................4 9
1 0. 2. 2 E xcl usi o n of Data fr o m A nal ysis ........................................................4 9
1 0. 2. 3 D e m o gra p hic a n d Baseli ne C haracteristics .........................................4 9
1 0. 2. 4 Treat me n ts (st u d y dr u g/ pr o d uct, resc ue me dicati o n, ot her 
c o nc o mita nt t hera pi[INVESTIGATOR_014], c o m plia nce) ...................................................[ADDRESS_195464]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 7 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195465] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: [ADDRESS_195466] u d y  E n d/ E n d of St u d y...............................................................[ADDRESS_195467]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 8 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195468] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: [ADDRESS_195469]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 9 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195470] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: [ADDRESS_195471] i vities ta ble pr o vi des a n o ver vie w of t he pr ot oc ol visits a n d pr oce d ures.
T he i n vesti gat or ma y sc he d ule visi ts ( u n pla n ne d visit s) i n a d ditio n  to t hose liste d o n t he 
sc he d ule of  act i vities, i n or der t o c o n d uct e val uati o ns or assess me nts re q uire d t o pr otect t he 
well - bei n g of t he s u bject.
T a bl e 1- 1 S c h e d ul e of A cti viti e s
Pr o c e d ur e/ A s s e s s m e nt S cr e e ni n g St u d y P eri o d
Vi sit 1
B et w e e n 2- 3 0 d a y sVi sit 2
Tr e at m e nt 
P eri o d 1
B et w e e n 2- 3 0 d a y sVi sit 3
Tr e at m e nt 
P eri o d 2
B et w e e n 2- 3 0 d a y sVi sit 4
Tr e at m e nt 
P eri o d 3
Inf or m e d c o n s e nt X
R e vi e w I n cl u si o n/ E x cl u si o n crit eri a X X X X
D e m o gr a p hi c s X
M e di c al hi st or y X
C urr e nt / C o n c o mit a nt tr e at m e nt s X X X X
D e nt al hi st or y X
O S T e x a mi n ati o n e d e nt ul o u s X XbXbXb
Cl e a n d e nt ur e scX X X X
Crit eri a f or w ell m a d e a n d fitti n g 
d e nt ur e s (r et e nti o n, st a bilit y, 
cli ni c al a c c e pt a bilit y a n d d e nt ur e 
fi ni s h)X
F o o d mi gr ati o n a d e q u a c y X
S u bj e ct eli gi bilit y X
Uri n e pr e g n a n c y t e steX XdXd
R a n d o mi s ati o n X
S u bj e ct c o nti n u a n c e X X X
Tr e at m e nt a p pli c ati o n a n d d e nt ur e 
i n s erti o na X X X
Effi c a c y a s s e s s m e nt - F o o d 
o c cl u si o n t e sti n gX X X
Effi c a c y a s s e s s m e nt - N u m b er of 
d e nt ur e di sl o d g e m e nt sX X X
P h ot o gr a p h of d e nt ur e s ( su b s et of 
s u bj e ct s)X X X
S u bj e ct -c o m pl et e d q u e sti o n n air e X X X
A d v er s e e v e nt s X X X
I n ci d e nt s X X X X
St u d y c o n cl u si o n X
A b bre viati o ns: O S T = Oral S oft Tiss ue.
A n y seri o us a d verse e ve nt assesse d as relate d t o st u d y partici pati o n t hat occ urs s u bse q ue nt t o t he si g ni n g of i nf or me d c o nse nt a n d a n y 
a d verse e ve nt t hat occ urs s u bse q ue nt t o t he first d ose will be rec or de d.
a  T here will be a 6 0  [ADDRESS_195472] a p plicati o n a n d als o after t he de nt ure re m o val a n d pea n ut rec o ver y.
c  De nt ures will be clea ne d b ot h pri or t o a n d after t he f o o d mi grat or y a de q uac y ( V 1) or f o o d occl usi o n testi n g assess me nt ( V 2 -4).
d  Pre g na nc y testi n g at Visits [ADDRESS_195473]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 1 0 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195474] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: [ADDRESS_195475] i on of  fo o d parti cle i n gress is ac hie ve d t hr o u g h a tig hter 
de nt ure fit pr o vide d b y t he de nt ure a d hesi ve t hr o u g h it s a bilit y t o b ot h a d here t he de nt ure t o 
t he m uc osa a n d t o o c clu de ga ps bet wee n t he de nt u re a n d t he m uc osa w hic h mi g ht ot her wise 
be s usce pti bl e t o fo o d p arti cle i n gress (Özca n, 2 0 0 5 ).  T he i ncrease d a d here nce t o t he m uc osa 
lea ds t o re d uce d m o ve me nt of  the de nt ure w hilst c he wi n g, lea di n g t o a re d ucti o n i n part icle 
mi grati o n u n der t he de nt ure (Tar bet, 1 9 8 0 ).  Ad diti o nall y , t he h y drat i on of  de nt ure a d hesi ves 
t hr o u g h c o ntact wit h sali va lea ds t o e x pa nsi o n of t he a d hesi ve, o c cl u di n g ga ps bet wee n t he 
de nt ure a n d t he u n derl yi n g m uc osa (Özca n, 2 0 0 5 ).  T he a d hesi ve ca n t heref ore be t ho u g ht of  
as f or mi n g a seal al o n g t he de nt ure b or ders w hic h pre ve nts i n gress o f s mall f o o d particles.
P u blis he d met h o d ol o gies f or e val uat i n g t he perf or ma nce of a de nt ure a d hesi ve at re d uci n g t he 
i n gress of f oo d p arti cles u n der t he de nt ure are rat her li mite d i n n u m bers.  Tar bet et al (Tar bet, 
1 9 8 0 ) ha d s u bjects s u bjecti vel y rate ( o n a te n-p oi nt scal e) w het her t he y e x perie nce d less f oo d
parti cles u n der t heir de nt ures aft er eat i n g f oo ds i ncl u di n g c el er y, stea k, taff y a p ples a n d 
sa n d wic hes w he n usi n g a de nt ure a d hesi ve c o m p are d t o n o a d hesi ve.  This st u d y sh o we d a 
statisticall y si g nifica nt differe nce ( p < 0. 0 1) i n s u bjecti ve sc ore i n fav o ur of  use of  ad hesi ve 
c o mpare d t o n o a d hesi ve use.  Ah ma d et al (A h ma d, 2 0 0 9 ; A h ma d, 2 0 1 0 ) descri be d a 
q ua n titati ve met h o d ol o g y base d u p o n ha vi n g f ull y e de nt ulo us s u bjects c he w a prescri be d 
a mo u nt of  pea n uts w hile weari n g b ot h t heir ma xillar y a n d ma n di b ular de nt ures.  After 
c he wi n g t he pea n uts, t he s u bjects br us he d t heir de nt ures w hilst still weari n g t he m, ri ns e d wit h 
water t he n re m o v e d t h ei r d e nt ur es.  St u d y st aff t h e n r e mo v e d t h e p e a n ut p articles fr om t he fit 
s urfaces of  the de nt ures a n d a n y a d hesi ve fr o m t he de nt ures a n d t he de nt ure beari n g tiss ues, 
was he d a n d sie ve d t he pea n ut particles a n d dri e d t he particl es pri or t o wei g hi n g t he m.  This 
st u d y was a ble t o s h o w statisticall y si g nifica nt l o wer wei g ht of  pea n uts c ollecte d bet wee n 
s u bjects usi n g a n a d hesi ve c o m pare d t o n o a d hesi ve use.  The w ei g ht of  pea n ut particles 
rec o vere d was n ot re p orte d i n f ull, h o we ver a mea n w ei g ht of  [ADDRESS_195476] u dies at t he U ni versit y of  Buff al o usi n g a si milar 
met h o d ol o g y  to A h ma d (L 3 5 1 0 5 6 6, 2 0 0 8 ; M u n oz, 2 0 1 2 ).  The i ncl usi on crit erio n f or Ka p ur 
( Ols ha n m o difie d) was, h o we ver, less stri n ge nt, all o wi n g s u bjects wi t h a sc ore ≥ [ADDRESS_195477] gr o u ps, a n d t h at t he ma ss of particles 
rec o vere d was s mall, ≤ [ADDRESS_195478]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 1 1 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195479] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: [ADDRESS_195480] u dies b y t he sa me pri nci ple i n vesti gat or ( PI) di d d e m o n strate t he 
a bilit y of  de nt ure a d hesi ves t o restrict t he i n gress of  fo o d u n der a de nt ures i n st u dies of  full 
( ; M u n oz -Vi ver os, 2 0 1 0 ) a n d parti al (M u n oz -Vi ver os, 
2 0 1 0 ; de nt ure wearers.  T hese st u di es us e d mo difie d c he wi n g a n d la b orat or y 
pr oce d ures a n d m o re stri n ge nt i ncl usi on crit eria.  These st u dies all d e m o nstrate d statisticall y 
sig nifica nt re d ucti o ns i n f o o d particle e ntra p me nt w he n usi n g a n a d hesi ve c o m pare d t o t he use 
of  n o a d hesi ve.
F o ll owi n g t he l oss of  the cli nical facilit y at U ni versit y of  Buff al o, G S K s p o ns ore d a st u d y 
(2 0 5 9 1 5, 2 0 1 6 ) r u n at S alus Researc h usi n g a si mil ar met h o d ol o g y , but t hi s st u d y w as u n a bl e 
t o d e mo nstrate a differe nce i n pea n ut mi grat i on bet wee n use of  a n ad hesi ve a n d n o a d hesi ve.  
A ke y differe nce bet wee n t he Sal us st u d y  a nd t he pre vi o us B uffal o st u di es was t he met h o d of 
a p plicat i on of t he a d hesi ve t o t he de nt ure.
T he ai m of  this st u d y is t o esta blis h a relia ble met h o d ol o g y  that is a ble t o c haracterise t he 
perf or m a nce of  the a d hesi ve i n ter ms of  re d uci n g f oo d i n gress i n a f oo d occl usi o n 
met h o d ol o g y  w h er e s u bj e cts are as ke d t o e at p e a n uts i n a c o ntr olle d ma n ner a n d t he mass of 
pea n ut particles u n der t he de nt ure, p ost pea n ut c o ns u m pt i on, i s meas ure d a n d c o mpare d.
T his st u d y  will be c o n d ucte d at Salus Researc h i n t he U S A.
1. 1 M e c h a ni s m of A cti o n/I n di c ati o n
S o di u m -calci u m mi xe d partial  salt of  pol y( me t h yl vi n ylet her/ maleic aci d) a n d 
car b o x y met h ylcell ul ose is c urre nt l y i ncl u de d i n a de nt ure a d hesi ve mar kete d b y G S K.  
De nt ure a d hesi ves f u ncti on b y f or mi n g a n a d hesi ve la yer bet wee n t he de nt ure a n d g u m 
s urface t hat ca n act as a p h ysical s hiel d w hic h ca n help re d uce t he i n gress of f o o d particles.
T his st u d y  will be c o n d ucte d i n patie nts wit h c o m plete ma xillar y a n d ma n di b ular de nt ures.
1. [ADDRESS_195481]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 1 2 of 6 2C CIC CI
C CI
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195482] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: [ADDRESS_195483] effic ie nt a p pr oac h t o e val uat i n g 
t heir p erf or m a nce wi t h differe nt a d hesi ves or ‘ n o a d hesi ve’ is a wi t hi n s u bject c o mparis o n 
(i.e. a cr oss o ver desig n).  De nt ure a d hesi ve is use d t o sec ure de nt ures i n t he m o ut h.  It f or ms a 
barrier t hat pre ve nts f oo d fr o m e nteri n g t he area bet wee n de nt ures a n d t he e de nt ulo us rid ge.  
T his st u d y will assess t he o bject i ve meas ure of  fo o d o c cl usi o n  while c he wi n g pea n uts as 
meas ure d b y mass of  pea n uts r etrie ve d, as well as s ubject i ve meas ures of  efficac y as 
meas ure d b y q uest i on naire data.
Pea n uts were c h ose n as t he m o d el  fo o d i n t his met h o d ol o g y  beca use t he y are a br ittle f oo d 
t hat, w he n masti c at e d, brea k i nto s mall particles t hat ca n be rec o vere d.  Pea n uts ha ve 
t heref ore bee n retai ne d as a m o d el  fo o d f or t hi s st u d y a nd t o allo w c o m par is o n wi t h pre vi o us 
data.
I n or der f or s u bjects t o be eli gi ble t he y must re p ort t hat t he y get f oo d tra p pe d u n der t heir 
de nt ures a n d t his m ust be e vi de nt f oll owi n g t he sta n dar dise d pea n ut mi grat i on a de q uac y 
testi n g at scree ni n g ( Visit 1).  This is t o e ns ure t hat meas ura ble a mo u nts of  pea n ut parti cles 
mi grate u n der t he de nt ure w he n n o de nt ure a d hesi ve is bei n g use d.  Whilst pea n ut aller g y is 
s pecific, pea n uts s u p plie d f or t his st u d y ma y t he msel ves be c o nta mi nate d wi t h ot her n uts 
o wi n g t o t he ma n ufact uri n g pr ocess.  Theref ore, s u bjects wi t h an y n ut aller g y are e xcl u de d 
fr om t his st u d y.  Su bjects wi t h te mp or o m a n di b ular j oi nt dis or ders are e xcl u de d s h o uld t he 
i n vesti gat or belie ves t hat t his c o uld affect t he s u bject’s partici pati o n, pri nci pall y re gar di n g t he 
a bilit y f or t he s u bject t o a de q uatel y c he w t he pea n uts.  Su bjects w h o use or ha ve e ver use d 
bis p h os p h o nate me d icati ons are s pecificall y e xcl u de d fr o m t his st u d y owi n g t o t he e n ha nce d 
ris k of  bis p h os p h o nat e-r elate d os t eo necr osi s of  the ja w ( B R O NJ) t hat is ass ociate d wi t h 
re d uce d tiss ue t oler a n c e t o f unct i on wi t h r e mo v a ble pr ost heses (Sal da n ha, 2 0 1 2 ).  S u bj e cts i n 
t his st u d y must be ha bi t ual wearers of  full de nt ures t o e ns ure t hat t he y are fa miliar wi t h 
c he wi n g wi t h their de nt ures i n place.  Su bjects w h o are xer ost o mic are e xcl u de d si nce t he 
pr o per f u nct i on of  de nt ure a d hesi ves re q uires a de q uate h ydrati o n f r o m sali va.
D uri n g t his st u d y, p h ot o gra p hs of  de nt ures wi t h pea n ut parti cles attac he d will be ta ke n.  The 
p ur p ose of  this is t o gat her re prese ntati ve p h ot o gra p hs of  the de nt ures t o ai d  in t he 
di sse mi nati on a n d i nter pretatio n of  t he r es ults, e. g. i n ma n uscri pt pre parati o n.  No pers o nall y 
i de ntifia ble i nf or mati on will be i ncl u de d i n t hese p h ot o gra p hs.  De m o gra p h y i nf or mat i on will 
be rec or de d as part of  this st u d y, i ncl u di n g a ge, race a n d ge n der.  I n acc or da nce wi t h t he 
U nite d States F o o d a n d Dr u g A d mi nistrati o n ( U S F D A) g ui deli nes (F D A, 2 0 0 5 ) t he et h ni cit y 
of  s u bjects will als o be ca pt ure d.
A n or al  sof t tiss ue ( O S T) e xa mi nat i on will b e c o n d ucte d at eac h tr e at me nt visi t bef ore 
treat me nt is a p plie d t o e ns ure t he s u bject’s or al  healt h is s ufficie nt t o all o w t he s u bject t o 
c o mplete t he assess me nts at t hat visit.  A furt her O S T e xa m will be p erf or m e d at eac h 
treat me nt visit after t he c o mpleti o n of  assess me nts t o assess f or p ossi ble A Es.
W hilst bli n di n g is a n i m p orta nt c o nsi derat i on f or a n y cli nical st u d y, t he o bj ecti ves of  this 
st u d y are n ot t o i n vesti gate pr o d uct efficac y, b ut t o de vel o p a met h o d ol o g y.   To f ulfil t he 
o bj ect i ves of  this st u d y it is n ot p ossi ble t o a de q uatel y mai nt ai n bli n di n g a n d t heref ore t his 
st u d y will be c o n d ucte d o pe n la bel. D oc u m e nt N a m e   
T y p e  V ersi o n  D oc u m e nt I d e ntifi er  Eff ecti v e D at e  
    
R e as o n F or Iss u e   
 
 
 
 
 
 
 
 
 
 
 
 
 [ADDRESS_195484]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 1 3 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195485] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: 2 2-J u n-2 0 1 7
Pa ge 1 4 of  6 2T he Ka p ur -Ols ha n i n de x is a c o m p osite sc ore base d u p o n sta bilit y an d rete nti on rati n gs f or 
t he ma xillar y a nd ma n di b ular de nt ures (Ka p ur, 1 9 6 7 ; Ols ha n, 1 9 9 2 ).  In t his st u d y, s u bject 
recr ui t me nt will be tar gete d t o ac hie ve a p pr o xi matel y e q ual n u m bers of  su bjects i n t he l ow 
a n d hi g h Ka p ur -Ol s ha n gr o u ps.  The l ow Ka p ur -Ols ha n gr o u p is defi ne d as a c o mp osi t e 
Ka p ur -Ols ha n sc ore of  6- 1 4 (cli nicall y fair a n d g o o d de nt ures) a n d t he hi g h Ka p ur -Ols ha n 
sc ore as 1 5 - 1 8 (cli nicall y v er y  go o d d e nt ur es), val ues deri ve d fr om c o nsi deratio n of  pr e vio us 
st u d y data (2 0 5 9 1 5, 2 0 1 6 ).  The p ur p ose of  this a nal ysis is t o e x pl ore t he o pti m u m i ncl usi on 
criteria f or f ut ure st u dies.  Su bjects prese nt i n g wi t h a ver y l ow Ka p ur -Ol s ha n sc ore at 
Scree ni n g ( < 6), defi ne d as “ Cli nicall y P o or” ( Ols ha n, 1 9 9 2 ), will be e xcl u de d fr om t his st u d y.
De nt ure a d hesi ve ac hie ves it s f unct i on b y p h ysical mea ns a n d o n c e c o mpletel y re m o v e d fr om 
t he de nt ure d oes n ot ha ve a n y resi d ual effects.  Theref ore, t he [ADDRESS_195486] u d y.
Mar kete d de nt ure a d hesi ves are c o m m o nl y e xtr u de d b y t he c o ns u mer o nt o t he de nt ure eit her 
t hr o u g h a flat rib b o n n ozzl e wi t h instr ucti o ns f or use t o “ da b” t he pr o d u ct o nt o t he de nt ure 
(t he c o n ve nt i onal a p plicat i on patter n) or t hr o u g h a fi ner n ozzl e t hat e na bles t he a d hesi ve 
pr o d uct t o be m o re precisel y a p plie d s o all o wi n g a c o nt i n u o us bea d of  pr o d uct ar o u n d t he 
b or ders of  the de nt ures (c o nti n u o us strips a p plicatio n patter n).  In t his met h o d de vel o p me nt 
st u d y bot h  ap plicat i on met h o ds will be e v aluate d, wi t h the a d hesi ve a p plie d via a s yri n ge, t o 
assess if t he met h o d ol o g y  is c o m pat i ble wi t h either or b ot h a p plicat i on met h o ds.  The use of 
t he s yrin ge all o ws f or greate r c o ntr ol of  dose a n d a p plicat i on patter n a n d is c o nsiste nt wi t h 
pre vi o us st u dies.
1. 2. [ADDRESS_195487] u d y :-
 S u per P oli gri p Free ( U S A mar ket place) a p plie d via a c o n ve nt i onal patter n.
 S u per P oli gri p Free ( U S A ma r k et place) a p plie d via a c o nti n u o us strips patter n.
 N o a d hesi ve.
A si n gle, c o m mo n  a d hesi ve will be use d ( S u per P oli grip F ree) wit h a c o m mo n d ose ( 1. 6 g) f or 
b ot h a p plicat i on met h o ds.  T he a d hesi ve will be e xtr u de d fr o m a pre -d ose d s yrin ge f oll owi n g 
t he a p plicati on i nstr uctio ns.  Su per P oli gri p Free has bee n selecte d as t he a d hesi ve i n t his 
st u d y as it is a c urre ntl y mar kete d pr o d uct a n d is c o nsi dere d a re prese ntati ve de nt ure a d hesi ve.  
1. [ADDRESS_195488]’s de nt ures , a n a mo u nt c o nsiste nt 
wi t h that use d i n pre vi o us st u dies a n d will t her ef or e facilitate c o mparis o n of  data fr om t his 
st u d y wi t h pre vi o us w or k.  This d ose will be s plit as 1. 0 0 ± 0. 0 5 g f or t he ma xillar y a n d 
0. 6 0 ± 0. 0 5 g f or t he ma n di b ular de nt ures i n acc or da nce wi t h c o ns u mer’s n or m al distri b uti on of 
a d hesi ve.
A n o a d hesi ve ne gat i ve c o ntr ol treat me nt has bee n c h ose n t o pr o vi de a c o nti n ual refere nce 
p oi nt t o all o w i nt er pretatio n of  t he r es ults a n d t o f a cilit at e c o mp aris o n of  t he r es ults fr om t his  D oc u m e nt N a m e   
T y p e  V ersi o n  D oc u m e nt I d e ntifi er  Eff ecti v e D at e  
    
R e as o n F or Iss u e   
 
 
 
 
 
 
 
 
 
 
 
 
 [ADDRESS_195489]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 1 4 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195490] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: [ADDRESS_195491] u d y with pre vi o us w or k, a n d is re prese ntati ve of  a si g nifica nt n u m ber of  de nt ure wearers 
w h o c urre ntl y d o n ot use a n a d hesi ve.
C o m plete i nf or mati on f or t his c o m p o u n d ma y be f ou n d i n t he si n gle refere nce safety 
d oc u m e nt ( S R S D), w hic h for t his st u d y  is t he S af et y State me nt .
[ADDRESS_195492] s i n t h e l o w a n d hi g h K a p ur -
Ol s h a n s u b gr o u p s.M a s s of p e a n ut s u n d er c o m bi n e d m a xill ar y 
a n d m a n di b ul ar d e nt ur e s i n e a c h s u b gr o u p 
(l o w a n d hi g h K a p ur -Ol s h a n s c or e s).
T o e x pl or e t h e r el ati o n s hi p b et w e e n t h e n u m b er of 
s u bj e ct -r e p ort e d d e nt ur e di sl o d g e m e nt s w h e n 
d e nt ur e a d h e si v e i s a p pli e d p er c o n v e nti o n al p att er n, 
c o nti n u o u s stri p s p att er n a n d w h e n n o a d h e si v e i s 
u s e d.T h e n u m b er of s u bj e c t r e p ort e d d e nt ur e 
di sl o d g e m e nt s d uri n g c h e wi n g.
S af et y
T o a s s e s s t h e t ol er a bilit y of m ar k et e d d e nt ur e 
a d h e si v e ( S u p er P oli gri p Fr e e).Tr e at m e nt e m er g e nt a d v er s e e v e nt s.
T his st u d y  is a met h o d de vel o p me nt st u d y a n d t heref ore t here is n o f or mal s uccess crit erio n. D oc u m e nt N a m e   
T y p e  V ersi o n  D oc u m e nt I d e ntifi er  Eff ecti v e D at e  
    
R e as o n F or Iss u e   
 
 
 
 
 
 
 
 
 
 
 
 
 [ADDRESS_195493]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 1 5 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195494] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: [ADDRESS_195495] t w o da ys bet wee n a djace nt treat me nt visits.
A p pr o xi matel y  4 8 ( ma xi m u m 50) healt h y s u bjects wi t h bot h  ma xillar y a n d ma n di b ular f ull 
de nt ures will be e nr olle d i n t his st u d y.  In t his st u d y, s u bject recr uitme nt  will be tar gete d t o 
ac hie ve a p pr o xi matel y e q ual n u m bers of  su bjects i n t he l ow a n d hi g h Ka p ur -Ols ha n gr o u ps.  
T he l ow Ka p ur -Ols ha n gr o u p is defi ne d as a c o mp osi t e Ka p ur -Ol s ha n sc ore of  6- 1 4 
(cli nicall y fair a n d g o o d de nt ures) a n d t he hi g h Ka p ur -Ols ha n sc ore as 1 5 - 1 8 (cli nicall y ver y 
g o o d de nt ures).
At  the scree ni n g visit, f oll owi n g a n O S T e xa mi nat i on, eac h s u bject’s de nt ures ( u p per a n d 
l ower) will be clea ne d t he n assesse d f or r et e ntio n a n d sta bilit y usi n g t he Ka p ur I n de x ( Ols ha n 
M o dificat i on) (Ka p ur, 1 9 6 7 ; Ols ha n, 1 9 9 2 ) a n d w het her t he y are well ma de.  Onl y  th ose 
s u bjects wi t h de nt ures ( b ot h u p per a n d l ower) t hat satisf y b ot h of  these crit eria will u n der g o 
t he f oo d mi grat i on a de q uac y assess me nt t o pr o vi de e vi de nce of  ade q uate pea n ut particle 
mi grati o n u n der t he de nt ures aft er c he wi n g a p orti o n of  pea n uts.  A vis ual o b ser vati on a n d 
rati n g of l ocatio n a n d e xt e nt of  p e a n ut p article mi grati o n a de q uac y m ust i n dicate > 0 o n a 0 –
[ADDRESS_195496] recr uitme nt  will be c o ntr olle d t o e ns ure 5 0 ± 1 0 % of  t he s u bjects will be i n 
eac h of t he l ow a n d hi g h Ka p ur -Ol s ha n gr o u ps [t he l ow Ka p ur -Ols ha n gr o u p is defi ne d as a 
c o mp osi te Ka p ur-Ols ha n sc ore of 6 -1 4 (cli nicall y fair a n d g o o d de nt ures) a n d t h e hig h Ka p ur -
Ol s ha n sc ore as 1 5 - 1 8 (cli nicall y ver y g o o d de nt ures)].  There will be bet wee n [ADDRESS_195497] da y ( Visits 2 -4) s u bjects will u n der g o a n O S T e xa mi nat i on a n d ha ve t heir 
de nt ures clea ne d. Treat me nt  ( or n o tr e at me nt as per t he ra n d o misatio n sc he d ule) will t he n be 
a p plie d as per t he a p plicati o n i nstr uctio ns a n d t he de nt ures w or n b y t he s u bject.  The n, 6 0  [ADDRESS_195498] i on naire o n efficac y a n d a f urt her 
O S T e xa mi nat i on will be perf or me d.
F or a s u bset of  su bjects t he fit surface of  their de nt ures will be p h ot o gra p he d bef ore pea n uts 
are c o llecte d fr om t he fit surf ace.  These s u bjects will be selecte d at t he discreti o n of  the 
I n vesti gat or, b ut all o w f or a v ari et y of  de nt ure sizes a n d fit to be re prese nte d.  It is e x pecte d 
t hat a p pr o xi matel y 5 sets of  de nt ures be p h ot o gra p he d per treat me nt gr o u p , a n d w here 
p ossi ble t hat c o nsiste nc y of  su bjects bet wee n tr e at me nts is mai ntai ne d (i.e. a s u bject will be 
i de ntifie d at visit  [ADDRESS_195499]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 1 6 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195500] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: [ADDRESS_195501] o p o uts or ot her reas o ns 
necessitate, s u bjects ca n be s u bstit ute d).
Pea n ut parti cles will t he n be c ollecte d fr o m t h e fit surf a c es of t he de nt ures a n d t he ga uzes a n d 
w ei g he d t o e val uate t he mass of f oo d particles t h at ha d mi grate d u n der t he de nt ure ( kee pi n g 
t he particles ass ociate d wit h t he u p per a n d l o wer de nt ures se parate).
T hese pr oce d ures will be re peate d i n a cr oss o ver ma n ner.  There will be bet wee n [ADDRESS_195502]’s first use of  treat me nt will be c o nsi dere d as a d verse 
e ve nts ( A Es).  I nci de nts will be rec or de d fr o m t he first use of a me dical de vice.
[ADDRESS_195503] eli gi b ility s h o uld be assesse d a n d d oc u me nte d b y a n a p pr o priate me m ber of  the 
i n vesti gat or’s st u d y t e a m bef ore s u bjects are e nr olle d i n t he st u d y.
S u bjects m ust meet all of  t he f oll owi n g i ncl usi on criteria t o be eli gi ble f or e nr o l me nt i nt o t he 
st u d y:
1) E vi de nce of a pers o nall y si g ne d a n d date d i nf or me d c o nse nt d oc u m e nt i n dicati n g t hat t h e 
s u bject has bee n i nf or me d of  all pert i ne nt as pects of  the st u d y befor e a n y assess me nt is 
perf or m e d.
2) Male or fema le w h o , at  the ti me of  scree ni n g , are bet wee n t he a ges of  18 a n d 8 5 ye ars, 
i ncl usi ve.
3) Willi n g a n d a ble t o c o m p l y wi t h sc he d ule d visit s, treat me nt pl a n, a n d ot h er stu d y 
pr oce d ures.
4) Heal t h y, defi ne d as i n ge neral g o o d p h ysical healt h, as j u d ge d b y  t he i n vesti gat or.
5) Self -re p orts e x perie nce of getti n g f o o d tra p pe d u n der t heir de nt ure.
6) Is a n ha bit ual wearer of b ot h of  t heir de nt ures defi ne d as s u bjects w h o wear b ot h of  t heir 
de nt ures f or t he maj orit y of  t h eir ti me w hilst a wa ke.
7) Fe male s of  chil d beari n g p ot e nti al an d at ris k f or pre g na nc y m ust a gree t o use a hi g hl y 
effect i ve met h o d of  c o ntrace ptio n t hr o u g h o ut t he st u d y  a nd f or [ADDRESS_195504] i on 4. 4. 2 .
8) Ha ve de nt ure pr ost hes es t hat f ulfil all of t he f oll o wi n g: D oc u m e nt N a m e   
T y p e  V ersi o n  D oc u m e nt I d e ntifi er  Eff ecti v e D at e  
    
R e as o n F or Iss u e   
 
 
 
 
 
 
 
 
 
 
 
 
 [ADDRESS_195505]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 1 7 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195506] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: 2 2-J u n-2 0 1 7
Pa ge 1 8 of  6 2a) A q ualif yi n g c o n ve nt i onal acr ylic f ull de nt ure i n b ot h t he u p per a n d l o wer arc h.
b) De nt ures are well fitti n g ( Ka p ur ( Ols ha n M o dificati o n) Rete nti o n a n d Sta bilit y I nde x 
S u m  Sc ore ≥ 6) (Ols ha n, 1 9 9 2 ) wit h n o i n di vi d ual sta bilit y or rete nti o n sc ores < 1.
c) De nt ures are well m a de (acc or di n g t o t he well -ma de assess me nt).
d) Has a pea n ut particle mi grati o n rat i n g > [ADDRESS_195507] u d y:
1. A n i n vesti gati o nal sit e staff me m ber di rectl y i n v ol ve d i n t he c o n d u ct of t he st u d y or t heir 
fa mil y me m ber, sit e staff me m bers ot h er wise s u per vise d b y t he i n vesti gat or, or a n 
e mpl o y ee of t he s p o ns or direct l y i n v ol ve d i n t he c o n d uct of t he st u d y.
2. P arti cip ati o n i n a n y ot h er cli nical st u d y in v o l vi n g i n vesti gati onal dr u gs, c os met ics or 
me dical de vices wit hi n [ADDRESS_195508] u d y  e ntr y a nd/ or d uri n g st u d y  p artici pat i on.
3. Ac ute or c hr o nic me dical or ps yc hiatric c o n diti o n or lab orat or y  ab n or m alit y that ma y 
i ncrease t he ris k ass o ciate d wit h st u d y partici pat i on or i n vesti gati onal pr o d uct 
a d mi nistrati o n or ma y i nterfere wi t h the i nter pretatio n of  st u d y res ults a n d, i n t h e 
j u d g me nt of  the i n vesti gat or, w o ul d ma ke t he s u bject i na p pr o priate f or e ntr y int o t his 
st u d y.
4. Pre g na nt fe male s u bjects.
5. Br eastfee di n g fe male s u bjects.
6. K n o w n or s us pecte d i ntol era nce or h y perse nsit i vity t o t he st u d y materials ( or cl o sel y 
r elate d c o mp o u n ds) or a n y  of t h eir state d i n gre die nts. 
7. U n willi n g or u na ble t o c o m pl y wit h t he Lifest yle G ui deli nes descri be d i n t his pr ot oc o l. 
8. Hi st or y of s wallo wi n g diffic ul ties or c h o ki n g.
9. C urre nt l y ta ki n g or ha ve ta ke n a bis p h os p h o nate dr u g (i.e., F osa ma x®, Act o n el®, B o ni va®) 
f or treat me nt of oste o p or osis .
1 0. A n y cli nicall y si g nifica nt or rele va nt or al  ab n or m alit y (e. g. t e mp or o m a n di b ular j oi nt
[ T MJ] pr o ble ms) t hat, i n t he o pi [INVESTIGATOR_9384] o n of  the i n vesti gat or, c o ul d affect t he s u bject’s 
parti ci pat i on i n t he st u d y.
[ADDRESS_195509] or y  ( wit hi n t he last year) of alc o h ol or ot her s u bsta nce a b use.
[ADDRESS_195510] u d y.
                                               
®F osa ma x is a re gistere d tra de mar k of Merc k & C o.
®Act o nel is a re gistere d tra de mar k of War ner C hilc ott C o m pa n y, L L C.
®B o n i va is a re gistere d tra de mar k of Ge ne ntec h. D oc u m e nt N a m e   
T y p e  V ersi o n  D oc u m e nt I d e ntifi er  Eff ecti v e D at e  
    
R e as o n F or Iss u e   
 
 
 
 
 
 
 
 
 
 
 
 
 [ADDRESS_195511]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 1 8 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195512] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: [ADDRESS_195513] selecti on 
criteria.  S u bjects s h o uld be recr uite d s o t hat, at  scree ni n g, a p pr o xi mately 5 0 % ( 4 0-6 0 %) of 
t he s u bject p o p ulat i on attai ns a Ka p ur -Ols ha n S c or e of  6- 1 4 a n d a p pr o xi matel y 5 0 % ( 4 0-
6 0 %) attai ns a Ka p ur -Ol s ha n Sc ore of [ADDRESS_195514] u d y (scree ni n g – L S L V):
 S u bjects will n ot be per mitte d t o ha ve a n y d e nt al / de nt ure w or k perf or me d d uri n g t he 
ti me t he y are i n t he st u d y, u nless di sc usse d a n d per mitte d b y t he e xa mi ner.  T his is t o 
ass ure t hat t he de nt ure fit will n ot be altere d d uri n g t he st u d y.
 S u bjects are n ot per mitte d t o use of bis p h os p h o nates as per e xcl usi o n cri t erio n 9.
D uri n g t he treat me nt visit s ( Visits 2-4):
 S u bjects will n ot be all o we d t o use t o bacc o or nic oti ne -c o ntai ni n g pr o d ucts f oll owi n g 
de nt ure i nserti o n u nt il aft er t heir de nt ures are ret ur ne d at c o mpl et i on of  the f oo d 
occl usi o n  t estin g .
 S u bjects will n ot be a ble t o use a n y or al  healt hcare pr o d uct ot her t ha n t hose s u p plie d 
b y t he i n vesti gat or f oll owi n g de nt ure i nserti o n u ntil af t er t h eir de nt ures are ret ur ne d at 
c o mplet i on of t he f o o d occl usi o n testi n g.
4. 4. 1 M e al s a n d Di et ar y R e stri cti o n s
S u bje cts will n ot be all o we d t o c o ns u me a n y fo o d (i ncl u di n g c he wi n g g u m ) or dri n ks 
f oll owi n g de nt ure i nserti o n u nt il aft er t heir de nt ures are ret ur ne d at c o mpleti o n of  the f oo d 
occl usi o n  testin g ( wit h the e xce pt i on of  small si ps of  water t o alle viate t hirst, t o ai d c he wi n g 
t he pea n uts or t o assist wit h me dicat i on).
4. 4. [ADDRESS_195515] of  co ntrace pti o n met h o ds (see bel o w) a n d has bee n i nstr ucte d b y a me dicall y 
q ualifie d i n di vi d ual i n its c o nsiste nt a n d c orrect use.  Su bjects nee d t o affir m t hat t he y meet  D oc u m e nt N a m e   
T y p e  V ersi o n  D oc u m e nt I d e ntifi er  Eff ecti v e D at e  
    
R e as o n F or Iss u e   
 
 
 
 
 
 
 
 
 
 
 
 
 [ADDRESS_195516]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 1 9 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195517] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: [ADDRESS_195518]’s c hart.  In a d ditio n, t he i n vesti gat or or his or her 
desi g nee will i nstr uct t he s u bject t o call i m me diatel y if t he selecte d c o ntrace pti o n met h o d is 
di sc o nti n ue d or if pre g na nc y is k n o w n or s us pecte d i n t he s u bject. 
Hi g hl y  effecti ve met h o ds of  co nt race pti o n are t hose t hat, al o ne or i n c o m bi nat i on, res ult i n a 
fail ure rate of  less t ha n 1 % per year w he n use d c o nsiste nt l y a n d c orrectl y (i.e., perfect use) 
a n d i ncl u de t he f oll o wi n g:
1. Esta blis he d use of oral , inserte d, i njecte d, tra ns der mal, or i m pla nte d h or m o nal met h o ds of 
c o ntrace pti o n is all o we d pr o vi de d t he s u bject pla ns t o re mai n o n t he sa me tr e at me nt 
t hr o u g h o ut t he e nt ire st u d y an d has bee n usi n g t hat h or m o nal c o ntrace pti ve f or a n 
a de q uate peri o d of ti me t o e ns ure effect i ve ness as dee me d a p pr o priate b y t he i n vesti gat or.
2. C orrectl y  place d c o p per-c o nt ai ni n g i ntra uteri ne de vice (I U D). 
3. Male c o n d o m  or fe m al e c o n d o m us e d WI T H a s per mici de (i.e., f oa m, g el, fil m, crea m, or 
s u p p osit or y).  For c o u n tries w here s per mici de is n ot a vaila ble or c o n d o m  plus s per mici de 
is n ot acce pte d as hi g hl y effect i ve c o ntrace pti o n, t his o pti o n is n ot a p pr o priate.
4. Male sterilisati o n wit h a bse nce of s per m i n t he p ost -vasect o m y ejac ulate.
5. Bilateral t u bal li gati on / bilateral sal pi n gect o m y or bilateral t u bal o c cl usi ve pr oce d ur e 
( pr o vide d t hat occl usi o n  has bee n c o nfir me d i n acc or da nce wit h t he de vice’s la bel).
6. Fe male w h o meets t he criteria f or n o n -c hil d beari n g p ote ntial as descri be d bel o w.  
Fe male s u bjects of  no n -c hil d beari n g p ot e nti al m ust meet at least o ne of  the f oll owi n g 
criteria:
a. Ac hie ve d p ost m e n o pa usal stat us, defi ne d as f oll o ws: cessat i on of  re g ular 
me nses f or at least 1 2 c o nsec uti ve m o nt hs wi t h n o alter nati ve pat h o l ogi cal or 
p h ysi o l ogical ca use; stat us ma y be c o nfir me d b y ha vi n g a ser u m fol licle-
sti m ulati n g h or m o ne ( F S H) le vel c o nfir mi n g t he p ost-me n o pa usal state;  
b. Ha ve u n der g o ne a d oc u me nte d h ysterect o m y a n d/ or bilateral o o p h orect o m y;
c. Ha ve me dicall y c o nfir me d o varia n fail ure.
All ot h er female s u bjects (i ncl u di n g fe males wi t h tu bal li gati ons) will be c o nsi dere d t o be of
c hil d beari n g p ote ntial.
4. [ADDRESS_195519] u d y but ar e 
n ot s u bse q ue ntl y ra n d o mise d. T o e ns ure tra ns pare nt re p ortin g of scree n fail ure s u bjects, a 
mi ni mal set of scree n fail u r e i nfor m atio n will i ncl u de de m o gra p h y, scree n fail ure details (e. g., 
wi t hdra wal  of c o nse nt), eli gi bility cri t eria, a n d a n y serio us a d verse e ve nts ( S A Es). 
I n di vi d uals w h o d o n ot meet t he crit eria for p arti ci p atio n i n t his st u d y  (scree n fail ure) ma y n ot 
be r e-scree ne d. D oc u m e nt N a m e   
T y p e  V ersi o n  D oc u m e nt I d e ntifi er  Eff ecti v e D at e  
    
R e as o n F or Iss u e   
 
 
 
 
 
 
 
 
 
 
 
 
 [ADDRESS_195520]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 2 0 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195521] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: 2 2-J u n-2 0 1 7
Pa ge 2 1 of  6 24. 6 S p o n s or’ s Q u alifi e d M e di c al P er s o n n el
T he c o ntact i nf or mat i on f or t he s p o ns or's a p pr o priatel y q ualifie d me dical/ de ntal pers o n nel f or 
t he st u d y is d oc u me nte d i n t he st u d y c o ntact list locate d i n t he St u d y  File.
T he c o ntact n u m ber ca n be use d b y i n vesti gati onal staff if t he y are see ki n g a d vice o n 
me dical/ de ntal q uest i ons or pr o ble ms; h o we ver, it s h o ul d be use d o nl y i n t he e ve nt t hat t he 
esta blis he d c o m m u nicati o n pat h wa ys bet wee n t he i n vesti gati onal sit e a n d t he st u d y tea m are 
n ot a vaila ble. It is t heref ore i nte n de d t o a u g me nt, b ut n ot  re place, t he esta blis he d 
c o m m u nicat i on pat h wa ys bet wee n t he i n vesti gati o nal sit e a n d t he st u d y tea m f or a d vice o n 
me dical/ de ntal q uest i ons or pr o bl e ms t hat ma y arise d uri n g t he st u d y. T he c o ntact n u m ber is 
n ot i nte n de d f or use b y t he s u bject direct l y, a n d if a s u bject calls t hat n u m ber, he or s he will 
be directe d bac k t o t he i n vesti gat i onal site.
T o facilitate access t o a p pr o priatel y q ualifie d me dical/ de ntal pers o n nel  on st u d y-r elate d 
me dical/ de ntal q uest i ons or pr o ble ms, s u bjects are pr o vi de d wi t h a co ntact car d. T he c o ntact 
car d c o ntai ns, at a mi ni m u m, pr ot oc ol  ide nt ifiers, s u bject st u d y nu m bers, c o ntact i nf or mati on 
f or t he i n vesti gati onal sit e, a n d c o ntact details i n t he e ve nt t hat t he i n vesti gati onal sit e staff
ca n n ot be reac he d t o pr o vi de a d vice o n a me d ical quest i on or pr o ble m i de ntifie d fr om t he 
s u bject’s healt hcare pr ofessi o n al  ot her t ha n t he i n vesti gat or.
5 S T U D Y T R E A T M E N T S
5. 1 Bli n di n g a n d All o c ati o n t o Tr e at m e nt/ R a n d o mi s ati o n
Treat me nts will be pr o vi de d i n a n o pe n -la bel ma n ner.  N o me m b ers of t h e st u d y  tea m will b e 
bli n d e d t o t h e tr e at m e nt allo c ati o n.  T h e i n vesti gat or’s k n o wle d g e of t h e tr e at me nt s h o uld n ot 
i nfl ue nce t he decisi o n  to e nr ol a part ic ular s u bject or affect t he or der i n w hic h s u bjects are 
e nr o lle d.
I n Ve nti v Heal t h will pr o vi d e a ra n d omisati o n sc he d ule t o t he st u d y site.  This c o nsists of  a 
series of  ra n d o misat i on n u m bers.  Eac h ra n d o misati on n u m ber lists 3 c orres p o n di n g 
alp ha bet ic treat me nt c o des, wi t h a uni q ue c o de assi g ne d f or eac h of  the 3 tr e at me nt  perio ds 
(e. g. treat me nt peri o d 1 = B, treat me nt peri o d 2 = A, treat me nt peri o d 3 = C).  The sc he d ule will 
als o detail w hic h tr e at me nt c o de c orres p o n ds t o eac h of  the [ADDRESS_195522] a vaila ble ra n d omisat i on n u m ber (eac h ra n d omisat i on 
n u m ber s h o uld o nl y be assi g ne d t o a si n gle s u bject).  The se q ue nce of  treatme nt s f or eac h 
ra n d omise d s u bject ca n t heref ore be rea d fr om t he ra n d omisat i on sc he d ule f or t hat s u bject’s 
ra n d omisat i on n u m ber.  The c orres p o n di n g ra n d o misati on tr e at me nt c o de will als o be pri nte d 
o n t he s u p plie d pr o d uct a p plicat i on i nstr uctio n s heets f or t he tr e at me nts e xce pt f or t he “ n o 
a d hesi ve” tr e at me nt.  Specific trai ni n g o n t his pr oce d ure will be carrie d o ut at  the Si t e 
I nitiatio n Visi t.
S u bject recr ui t me nt will be c o ntr olle d t o e ns ure 5 0 ± 1 0 % of t he s u bjects will be i n e a c h of t he 
l ow a n d hi g h Ka p ur -Ols ha n gr o u ps [t he l ow Ka p ur -Ols ha n gr o u p is defi ne d as a c o m p osite  D oc u m e nt N a m e   
T y p e  V ersi o n  D oc u m e nt I d e ntifi er  Eff ecti v e D at e  
    
R e as o n F or Iss u e   
 
 
 
 
 
 
 
 
 
 
 
 
 [ADDRESS_195523]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 2 1 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195524] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: 2 2-J u n-2 0 1 7
Pa ge 2 2 of  6 2Ka p ur -Ols ha n sc ore of  6- 1 4 (cli nicall y fair a n d g o o d de nt ures) a n d t he hi g h Ka p ur -Ols ha n 
sc ore as 1 5-1 8 (cli nicall y ver y g o o d de nt ures)].
5. [ADDRESS_195525] u d y  pr o d ucts will be s u p plie d b y t he Cli nical S u p plies De part me nt, G S K C H:
Test Pr o d uct 
( C o n ve nti o n al 
A p plic ati o n)Test Pr o d uct 
( C o nti n u o us Stri ps 
A p plic ati o n)Ne g ati ve C o ntr ol
Pr o d uct N a me S u per P oli gri p®Free 
De nt ure A d hesi ve 
Crea m  ( U S A 
Mar ket place)S u per P oli gri p®Free 
De nt ure A d hesi ve Crea m 
( U S A Mar ket place)N o A d hesi ve
Pr o d uct 
F or m ul ati o n 
C o deN/ A
D ose 1. 6 g of a d hesi ve 
a p plie d as 1. 0 g f or 
ma xillar y  de nt ure a n d 
0. 6 g f or m a n di b ular 
de nt ure.1. 6 g of a d hesi ve a p plie d 
as 1. 0 g f or ma xillar y 
de nt ure a n d 0. 6 g f or 
ma n di b ular de nt ure.N/ A
R o ute of 
A d mi nistr ati o nA p plie d t o de nt ure 
w hic h is place d i n 
m o ut hA p plie d t o de nt ure w hic h 
is place d i n m o ut hN/ A
D osi n g 
I nstr ucti o nsAs per t he Pr o d uct 
A p plicat i on I nstr ucti o nsAs per t he Pr o d uct 
A p plicat i on I nstr ucti o nsN/ A
Ot her ite ms t o be s u p plie d b y t he Cli nical S u p plies De part me nt, G S K C H:
 Or al  B®De nt ure br us he s - t o clea n de nt ures.
 P oli de nt®De nt u Crè me De nt ure clea nsi n g paste ( U S A mar ket place) - t o clea n 
de nt ures.
 S y rin ges - t o a p pl y a d hesi ve t o de nt ures.
 S y rin ge ca ps - t o pr otect pre-fille d s yri n ges.
 Pre g na nc y test kits.
                                               
®P oli gri p is a re gistere d tra de mar k of Gla x o S mit h Kli ne C o ns u mer Healt hcare.
®Oral B is a re gistere d tra de mar k of Pr oct or & Ga m ble.
®P oli de nt De nt u Crè me is a re gistere d tra de mar k of Gla x o S mit h Kli ne C o ns u mer Healt hcare. D oc u m e nt N a m e   
T y p e  V ersi o n  D oc u m e nt I d e ntifi er  Eff ecti v e D at e  
    
R e as o n F or Iss u e   
 
 
 
 
 
 
 
 
 
 
 
 
 [ADDRESS_195526]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 2 2 of 6 2C CI C CI
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195527] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: [ADDRESS_195528] 1 - 2 i nc hes of  ad hesi ve s hall be e xtr u de d a n d di s p ose d.  S u p plie d s yri n ges 
will be fille d b y t he sit e pers o n nel s o t hat t he y c o ntai n 1. 0 0 ± 0. 0 5 g or 0. 6 0 ± 0. [ADDRESS_195529]’s de nt ures will first be clea ne d pri or t o a p plicat i on of a d hesi ve, or n o a d hesi ve.  Usi n g 
t he s u p plie d de nt ure b r us h a n d clea nsi n g paste, b ot h t he u p per a n d l ower de nt ures will be 
t hor o u g hl y clea ne d t o re m o ve all traces of  de nt ure fi xati ve, pla q ue a n d partic ulates/ de bris.  
De nt ures s h o ul d t he n be drie d.
A d hesi ve is a p plie d t o de nt ures b y e xtr u di n g all of  the pre -w ei g he d a d hesi ve fr om s yri n ges 
o nt o t he de nt ures per t he Pr o d uct A p plicat i on I nstr ucti o ns .  T he de nt ures will t he n be ret ur ne d 
t o t he s u bject w h o s h o uld r e p osi tio n t he de nt ures i n t hei r m o ut h a n d bit e d o w n t o sec ure h old.  
F or s u bjects o n t he “ n o a d hesi ve” treat me nt visit, t he de nt ures s h o uld b e cl e a n e d a n d dri e d as 
a b o ve, t he n refitte d b y t he s u bject.
5. 4. [ADDRESS_195530] u d y , fr o m t he a d mi nistratio n or c o ns u m pti o n o f: 
 t he wr o n g pr o d uct,
 b y t he wr o n g s u bject, 
 at t he wr o n g ti me,  D oc u m e nt N a m e   
T y p e  V ersi o n  D oc u m e nt I d e ntifi er  Eff ecti v e D at e  
    
R e as o n F or Iss u e   
 
 
 
 
 
 
 
 
 
 
 
 
 [ADDRESS_195531]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 2 3 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195532] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: 2 2-J u n-2 0 1 7
Pa ge 2 4 of  6 2 or at t he wr o n g d osa ge a m o u nt ( ot her e xa m ples of c o ncer n ma y be a d de d base d o n 
t he i n vest i gati onal pr o d uct a d mi nistrati o n, s uc h as i na d verte nt e x p os ure).  
S uc h me dicat i on err ors occ urri n g t o a st u d y partici pa nt are t o be ca pt ure d i n t he C R F.  In t he 
e ve nt of me dicat i on d osi n g err or, t he s p o ns or s h o ul d be n otifie d i m me diatel y .
Me dicat i on err ors are re p orta ble irres pecti ve of t he prese nce of  an ass ociate d A E/ S A E, 
i ncl u di n g:
 Me dicat i on err ors i n v o l vi n g s u bject e x p os ure t o t he i n vesti gati onal pr o d uct;
 P ote nti al me dicat i on err ors or uses o utsi de of  what is f oresee n i n t he pr ot oc ol  t hat 
d o or d o n ot i n v o l ve t he partici pati n g s u bject.
W het her or n ot a me d icatio n err or is acc o m p a nie d b y a n A E, as deter mi ne d b y t he 
i n vesti gat or, t he me d icati on err or a n d, if a p plica ble, a n y ass o ciate d a d verse e ve nt(s) is 
ca pt ure d o n a n a d verse e ve nt ( A E) C R F pa ge.
5. [ADDRESS_195533] be ca pa ble of  meas uri n g a n d d oc u m e nt i n g (for e xa m ple, via a l og), at a 
mi ni m u m, dail y mi ni m u m a n d ma xi m u m t e mperat ures f or all sit e st ora ge l ocatio ns (as 
a p plica ble, i ncl u di n g fr oze n, refri gerate d, a n d/ or r o o m-t e mperat ure pr o d ucts).  T hi s s h o uld be 
ca pt ure d fr o m t he time of  in vest i gati onal pr o d uct recei pt t hr o u g h o ut t he st u d y.  Eve n f or 
c o nti n u o us m o nit ori n g s yste ms, a l o g or si te pr oce d ure t hat e ns ures acti ve dail y e val uati o n f or 
e xc ursi o ns s h o uld be a vaila ble.  The o p er ati o n of  the t e mpe rat ure-m o nit ori n g de vice a n d 
st ora ge u nit (f or e xa m ple, r efrigerat or), as a p plica ble, s h o uld be re g ularl y i ns pecte d t o e ns ur e 
it is mai ntai ne d i n w or ki n g or der. 
A n y e xc ursi o ns fr o m t he pr o d uct -label st ora ge c o n dit i ons s h o uld be re p orte d u p o n disc o ver y.  
T he sit e s h o uld acti vel y purs ue o pti o ns f or ret ur ni n g t he pr o d uct t o t he st ora ge c o n ditio ns as 
descri be d i n t he la belli n g, as s o o n as p ossi ble.  De viat i ons fr om t he st ora ge re q uire me nts, 
i ncl u di n g a n y acti ons ta ke n, m ust be d oc u me nte d a n d re p orte d t o t he S p o ns or.  
O nce a n e xc ursio n is i de ntifie d, t he i n vesti gati onal pr o d uct m ust be q uara nt i ne d a n d n ot use d 
u nt il t he S p o ns or pr o vid es d o c u m e nt atio n of  p er missio n  t o us e t h e i n v estigat i on al pr o d u ct.  It 
will n ot be c o nsi dere d a pr ot oc ol de viat i on if t he s p o ns or a p pr o ves t he use of  the 
i n vesti gati onal pr o d uct aft er t he t e mperat ure e xc ursi o n. Use of  the i n vesti gati o nal pr o d uct 
pri or t o s p o ns or a p pr o val will be c o nsi dere d a pr ot oc ol  de viat i on.  Specific details re gar di n g 
i nf or mat i on t he site s h o ul d re p ort f or eac h e xc ursi o n will be pr o vi de d t o t he site. 
5. [ADDRESS_195534]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 2 4 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195535] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: [ADDRESS_195536] u g acc o u nta bilit y f or m/rec or d. 
T he i n ve nt or y must be a vaila ble f or i ns pecti on b y t he st u d y mo ni t or d uri n g t he st u d y. 
M o ni t ori n g of  treat me nts acc o u nta bilit y will  be perf or m e d b y t he fiel d m o nit or d uri n g sit e 
visit s a n d at t he c o m pleti on of t he st u d y.
5. 6. [ADDRESS_195537] f or t his cli nical 
stu d y (e m pty c o ntai ners), as well as all u n use d st u d y pr o d uct will be ret ur ne d t o t he 
desi g nate d ve n d or usi n g t he ret ur n s hi p pi n g i nstr ucti o ns pr o vi de d. 
5. [ADDRESS_195538] or y ( wit hi n t he last year ), i ncl u di n g 
aller gies or dr u g se nsit i vity, will be rec or de d i n t he C R F.  T he use of c o nc o mita nt me dicat i ons 
is per mi tt e d i n t his st u d y with t he e xce pt i on of  the use of  bis p h os p h o nate dr u gs (e xcl usi o n 
crit erio n 9) a n d me dicat i ons t hat i n t he o pi [INVESTIGATOR_9384] o n  of t he i n vesti gat or w o ul d i nterfere wi t h the 
c o n d uct of t his st u d y (e xcl usio n  crit erio n 1 5).
Treat me nts ta ke n aft er t he first d ose of  st u d y in vesti g ati o nal pr o d uct will be d o c u m e nte d as 
c o nc o mita nt treat me nts.
All c o nc o mit a nt treat me nts ta ke n d uri n g t he st u d y mu st be rec or de d wi t h in dicat i on, u ni t 
d ose, dail y d ose, a n d start a n d st o p dates of  ad mi nistrati o n.  All s u bjects will be q uest i one d 
a b o ut c o nc o mita nt treat me nt at eac h cli nic visit.
S u bjects will be as ke d n ot t o ha ve a n y n o n- e mer ge nc y d e nt al / de nt ure w or k p erf or me d d uri n g 
t he ti me t he y are i n t he st u d y, u nless disc usse d a n d per mitte d b y t he e xa mi ner.  This is t o 
ass ure t hat t he de nt ure fit will n ot be altere d d uri n g t he st u d y.
5. [ADDRESS_195539]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 2 5 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195540] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: 2 2-J u n-2 0 1 7
Pa ge 2 6 of  6 26 S T U D Y P R O C E D U R E S
6. 1 S T U D Y P E RI O D
6. 1. 1 S cr e e ni n g - Vi sit 1
T he f oll owi n g pr o ce d ures/assess me nts will ta ke pl ace i n t he or der liste d bel o w ( w here 
p ossi ble), a n d rec or de d i n t he C R F:
 O btai n writte n i nf or me d c o nse nt.  
 C ollect de m o gra p h y  ( year of birt h, ge n der, race a n d et h nicity) .
 O btai n me dical hist or y , i ncl u di n g hist or y of ille gal dr u g, alc o h o l a n d t o bacc o use.
 O btai n De ntal  Hist or y.
 O btai n c o m p lete me d icati on hist or y of  all pr es cripti o n or n o n -prescri pt i on dr u gs, a n d 
di et ar y a n d her bal s u p ple me nts ta ke n wit hi n [ADDRESS_195541] d ose.
 Perf or m  O S T E xa mi nat i on- E de nt ul o us .
 Cl ea n t he s u bject’s de nt ures usi n g t he s u p plie d de nt ure br us h a n d clea nsi n g paste, 
b ot h t he u p per a n d l ower de nt ures will b e t hor o u g hl y clea ne d t o r e mo ve all traces of  
de nt ure fi xat i ve, pla q ue a n d partic ulates/ de bris. De nt ures s h o ul d t he n be drie d.
 Perf or m  t he Well -Ma de Assess me nt .
 Perf or m  t he Well -Fi t Assess me nt.
 Perf or m  t he F o o d Mi grati o n A de q uac y Assess me nt .
 Re vie w I ncl usi o n a n d E xcl usi o n cri t eria.  Pre g na nc y stat us will be c o nfir me d ver ball y 
b y t he s u bject.
 Assess s u bject eli gi bilit y.
 A n y seri o us a d verse e ve nt assesse d as relate d t o st u d y p artici pat i on t hat occ urs 
s u bse q ue nt t o t he si g ni n g of i nf or me d c o nse nt will be rec or de d.
T o pre pare f or st u d y parti ci pat i on, s u bjects will be i nstr ucte d o n t he use of  the Lifest yle 
G ui deli ne s a n d C o nc o mit a nt Treat me nt(s) secti o ns of t he pr ot oc ol.
6. 1. 2 Vi sit 2
S u bjects will be a d mitt e d t o t he cli nical sit e bet wee n 2 - 3 0 d a y s aft er Scree ni n g.  The 
f oll owi n g pr oce d ures will be c o m p lete d i n t he f oll owi n g or der ( w here ver p o ssi ble) a n d 
rec or de d i n t he C R F:
 Re vie w I ncl usi o n a n d E xcl usi o n cri t eria.  Pre g na nc y stat us will be c o nfir me d ver ball y 
b y t he s u bject.
 C ollect uri ne pre g na nc y test f or fe males of c hil d beari n g p ote ntial. 
 C o nfir m pr o per c o ntrace pti o n is bei n g use d.
 Re vie w c ha n ges i n t he s u bject’s me dical hist or y  incl u di n g me dicat i on hist or y  si nce 
Scree ni n g.
 Perf or m  O S T E xa mi nat i on- E de nt ul o us . D oc u m e nt N a m e   
T y p e  V ersi o n  D oc u m e nt I d e ntifi er  Eff ecti v e D at e  
    
R e as o n F or Iss u e   
 
 
 
 
 
 
 
 
 
 
 
 
 [ADDRESS_195542]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 2 6 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195543] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: 2 2-J u n-2 0 1 7
Pa ge 2 7 of  6 2 Assess s u bject eli gi bilit y.
 Ra n d o mise s u bject t o treat me nt gr o u p.
 Cl ea n t he s u bject’s de nt ures usi n g t he s u p plie d de nt ure br us h a n d clea nsi n g paste, 
b ot h t he u p per a n d l ower de nt ures will b e t hor o u g hl y clea ne d t o r e mo ve all traces of  
de nt ure fi xat i ve, pla q ue a n d partic ulates/ de bris. De nt ures s h o ul d t he n be drie d.
 A p pl y treat me nt a n d i nsert de nt ures per t he Pr o d uct A p plicati o n I nstr ucti o ns .
 6 0 ± [ADDRESS_195544] i n g i ncl u di n g 
De nt ure Di slo d ge me nt Assess me nt .
 Rec or d t he n u m ber of de nt ure disl o d ge me nts d uri n g pea n ut c he wi n g.
 S u bjects c o m plete t he q uesti o n naire.
 P h ot o gra p h de nt ures f or a s u bset of s u bjects.
 Perf or m  O S T E xa mi nat i on- E de nt ul o us .
 Ret ur n cl ea n de nt ures t o s u bject.
 Rec or d A Es a n d i nci de nts. Assess s y m pt o ms b y s p o nta ne o us re p orti n g of  ad verse 
e ve nts a n d b y as ki n g t he s u bjects t o r es p o n d t o a n o n- lea di n g q uest i on s uc h as “ H o w 
d o y o u feel?”  A n y a d verse e ve nt t hat occ urs s u bse q ue nt t o t he first d ose will be
rec or de d.
6. 1. 3 Vi sit 3
S u bjects will be a d mitt e d t o t he cli nical sit e bet wee n 2 - 3 0 da ys aft er Visi t 2.  The f oll owi n g 
pr oce d ures will be c o m p lete d i n t he f oll o wi n g or der ( w here ver p ossi ble) a n d rec or de d i n t he 
C R F:
 Re vie w I ncl usi o n a n d E xcl usi o n cri t eria.  Preg na nc y  stat us will be c o nfir me d ver ball y 
b y t he s u bject.
 C ollect uri ne pre g na nc y t est f or fe males of  chil d beari n g p ot e nti al if re q uire d per 
Secti o n 7. 3. 2 .
 Re vie w c ha n ges i n t he s u bject’s me dical hist or y  incl u di n g me dicat i on hist or y  si nce 
Scree ni n g.
 Perf or m  O S T E xa mi nat i on- E de nt ul o us .
 Assess s u bject eli gi bilit y.
 Cl ea n t he s u bject’s de nt ures usi n g t he s u p plie d de nt ure br us h a n d clea nsi n g paste, 
b ot h t he u p per a n d l ower de nt ures will b e t hor o u g hl y clea ne d t o r e mo ve all traces of  
de nt ure fi xat i ve, pla q ue a n d partic ulates/ de bris. De nt ures s h o ul d t he n be drie d.
 A p pl y treat me nt a n d i nsert de nt ures per t he Pr o d uct A p plicati o n I nstr ucti o ns .
 6 0 ± [ADDRESS_195545] i n g i ncl u di n g 
De nt ure Di slo d ge me nt Assess me nt .
 Rec or d t he n u m ber of de nt ure disl o d ge me nts d uri n g pea n ut c he wi n g.
 S u bjects c o m plete t he q uesti o n nair e.
 P h ot o gra p h de nt ures f or a s u bset of s u bjects. D oc u m e nt N a m e   
T y p e  V ersi o n  D oc u m e nt I d e ntifi er  Eff ecti v e D at e  
    
R e as o n F or Iss u e   
 
 
 
 
 
 
 
 
 
 
 
 
 [ADDRESS_195546]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 2 7 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195547] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: 2 2-J u n-2 0 1 7
Pa ge 2 8 of  6 2 Perf or m  O S T E xa mi nat i on- E de nt ul o us .
 Ret ur n cl ea n de nt ures t o s u bject.
 Rec or d A Es a n d i nci de nts. Assess s y m pt o ms b y s p o nta ne o us re p orti n g of  ad verse 
e ve nts a n d b y as ki n g t he s u bjects t o res p o n d t o a n o n-lea di n g q uest i on s uc h as “ H o w 
d o y o u f eel?”
6. 1. 4 Vi sit 4
S u bjects will be a d mitt e d t o t he cli nical sit e bet wee n 2 - 3 0 da ys aft er Visi t 3.  The f oll owi n g 
pr oce d ures will be c o m p lete d i n t he f oll o wi n g or der ( w here ver p ossi ble) a n d rec or de d i n t he 
C R F:
 Re vie w I ncl usi o n a n d E xcl usi o n cri t eria.  Pre g na nc y stat us will b e c o nfi r me d ver ball y 
b y t he s u bject.
 C ollect uri ne pre g na nc y t est f or females of c hil d beari n g p ot e nti al if re q uir e d per 
Secti o n 7. 3. 2 .
 Re vie w c ha n ges i n t he s u bject’s me dical hist or y i ncl u di n g me dicati o n hist or y si nce 
Scree ni n g.
 Perf or m  O S T E xa mi nat i on- E de nt ul o us .
 Assess s u bject eli gi bilit y.
 Cl ea n t he s u bject ’s de nt ures usi n g t he s u p plie d de nt ure br us h a n d clea nsi n g paste, b ot h 
t he u p per a n d l ower de nt ures will be t hor o u g hl y clea ne d t o re m o ve all traces of 
de nt ure fi xat i ve, pla q ue a n d partic ulates/ de bris. De nt ures s h o ul d t he n be drie d.
 A p pl y treat me nt a n d i nse rt de nt ures per t he Pr o d uct A p plicati o n I nstr ucti o ns .
 6 0 ± 5 mi n utes after de nt ure i nserti o n, be gi n F o o d Occl usi o n  Testi n g i ncl u di n g De nt ure 
Di slo d ge me nt Assess me nt .
 Rec or d t he n u m ber of de nt ure disl o d ge me nts d uri n g pea n ut c he wi n g.
 S u bjects c o m plete t he q uesti o n naire.
 P h ot o gra p h de nt ures f or a s u bset of s u bjects.
 Perf or m  O S T E xa mi nat i on- E de nt ul o us .
 Ret ur n cl ea n de nt ures t o s u bject .
 Rec or d A Es a n d i nci de nts. Assess s y m pt o ms b y s p o nta ne o us re p orti n g of a d verse 
e ve nts a n d b y as ki n g t he s u bjects t o res p o n d t o a n o n- lea di n g q uest i on s uc h as “ H o w 
d o y o u f eel?”
 St u d y  c o nclusi o n .
If a s u bject has a n y cli nicall y si g nifica nt, st u d y-r elate d a b n or malit ies at t he c o nclusi o n  of a 
sc he d ule d i n patient  porti o n of  the st u d y, t he G S K C H me dical m o nit or ( or desi g nate d 
re prese ntati ve) s h o ul d be n otifie d a n d de pe n di n g o n t he a b n or mality,  t he s u bject ma y be as ke d 
t o r e mai n at t he cli nical sit e u nt il s uc h a b n or malit ies are dee me d n ot cli nicall y si g nifica nt, or 
it is s afe f or o ut pati e nt f oll ow- u p.  If t he s u bject is u na ble or u n willi n g t o re mai n at t he 
cli nical sit e a n d/ or w he n o ut pati e nt f oll ow- u p is dee m e d a p pr o priate, t he G S K C H me dica l  D oc u m e nt N a m e   
T y p e  V ersi o n  D oc u m e nt I d e ntifi er  Eff ecti v e D at e  
    
R e as o n F or Iss u e   
 
 
 
 
 
 
 
 
 
 
 
 
 [ADDRESS_195548]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 2 8 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195549] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: 2 2-J u n-2 0 1 7
Pa ge 2 9 of  6 2m o nit or ( or d esi g n ate d re prese ntati ve) s h o uld b e s o n otifie d, a n d t he i n vestig at or s h o ul d ma ke 
e ver y effort t o arra n ge f oll ow- u p e val uat i ons at a p pr o priate i nter vals t o d oc u me nt t he c o urse 
of  t he a b n or malities.
6. [ADDRESS_195550] u d y treat me nt a n d/ or pre mat ure 
s u bject wit h dra wal:
 Pr ot oc ol  viol at i on t hat m a y i m pact t he o utc o me of t he s u bject’s safety
 Wit h dra wal o f i nf or me d c o nse nt
 S u bject l ost t o f oll o w - u p 
 Pre g na nc y
 Deat h
If a s u bject is disc o nt i n ue d or pre mat urel y wi t hdra ws fr om t he st u d y, reas o ns f or 
di sc o nti n uati on or wi t hdra wal  an d ass o ciate d date m ust be d oc u me nte d i n t he rele va nt 
secti on(s) of t he C R F. 
If a s u bject d oes n ot ret ur n f or a sc he d ule d visit, e ver y eff ort s h o ul d be ma de t o c o ntact t he 
s u bject.  T he I n vesti gat or or site staff s h o ul d atte m pt t o c o ntact t he s u bject t wice.  After t w o 
atte mpts, cli nical  site staff m ust se n d a re gistere d letter.  If n o res p o nse is recei ve d fr om t he 
s u bject, t he s u bject will be c o nsi dere d l ost t o f o ll ow u p.  All atte m pts t o c o ntact t he s u bject 
a n d i nf or mat i on recei ve d d uri n g c o ntact atte m pts m ust be d oc u me nte d i n t he C R F.  I n a n y 
circ u msta nce, e ver y effort s h o ul d b e m a de t o d oc u me nt s u bject o utc o me, if p ossi ble.  T he  D oc u m e nt N a m e   
T y p e  V ersi o n  D oc u m e nt I d e ntifi er  Eff ecti v e D at e  
    
R e as o n F or Iss u e   
 
 
 
 
 
 
 
 
 
 
 
 
 [ADDRESS_195551]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 2 9 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195552] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: [ADDRESS_195553] i gat or’s discreti on.
Lac k of  co m plet i on of  all or a n y of  the earl y ter mi nati on pr oce d ures will n ot be vie we d as 
p r ot oc ol de viati ons s o l o n g as t he s u bject’s safet y was preser ve d.
If t he s u bject wi t hdra ws fr om t he st u d y an d als o wi t hdra ws c o nse nt f or discl o s ure of  fut ure 
i nf or mat i on, n o f urt her e val uat i ons s h o uld be p erf or m e d a n d n o a d ditio nal data s h o uld be 
c ollecte d.  The s p o ns or ma y retai n a n d c o nt i n ue t o use a n y data c ollecte d bef ore s uc h 
wi t hdra wal  of c o nse nt.
[ADDRESS_195554] o btai n wri tte n (sig ne d a n d date d b y t he s u bject) i nf or me d 
c o nse nt fr o m eac h s u bject parti ci pat i n g i n t his st u d y after a de q uate e x pla nati o n of t he ai ms, 
met h o ds, o bj ect i ves, a n d p ot e nti al hazar ds of  the st u d y. T he i n vesti gat or, or desi g nee, m ust 
als o e x plai n t o t he s u bjects t hat t he y are c o mpletel y  free t o ref use t o e nter t he stu d y or t o 
wi t hdra w fr om it  at a n y time. A p pr o pri ate f or ms f or d oc u m e nt in g a wri tte n c o nse nt will b e 
pr o vi de d b y t he i n vesti gat or or b y G S K C H. T he i n vesti gat or, or desi g nee, s h o uld si g n a n d 
date t he c o nse nt f or m to c o nfir m t hat t he c o nse nt pr ocess was c o m p lete d c orrectl y. T he 
s u bject, will be pr o vi de d wi t h a co p y  of t heir si gne d a n d date d c o nse nt f or m an d a n y ot h er 
wri tte n i nf or mati o n w hic h t he y s h o uld be i nstr ucte d t o retai n.  If, duri n g a s u bject’s 
parti ci pat i on i n t he st u d y, a n y ne w i nf or mati on bec o me s a vaila ble t hat ma y affect t he 
s u bject’s willi n g ness t o partici pate i n t he st u d y, eac h o n g oi n g s u bject s h o uld recei ve a c o p y  of 
t his ne w i nf or mati on a n d be r e-c o nse nte d i nto t he st u d y. S u bjects will be pr o vi de d wi t h a  D oc u m e nt N a m e   
T y p e  V ersi o n  D oc u m e nt I d e ntifi er  Eff ecti v e D at e  
    
R e as o n F or Iss u e   
 
 
 
 
 
 
 
 
 
 
 
 
 [ADDRESS_195555]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 3 0 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195556] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: [ADDRESS_195557] is a re g ular user of  
de nt ure a d hesi ves. 
7. 1. 3 W ell -Fit A s s e s s m e nt, K a p ur ( Ol s h a n M o difi c ati o n) I n d e x
Eac h de nt ure ( u p per a n d l ower) will be e xa mi ne d f or rete nti o n a n d sta bilit y usi n g t he Ka p ur 
I n de x ( Ols ha n M o dificat i on) (Ka p ur, 1 9 6 7 ; Ols ha n, 1 9 9 2 ) b y a n e xa mi ner wi t h ex pert 
k n o wl e d ge of pr ost h o d o ntics.  A s u m sc ore ( u p per + l o wer) of ≥ 6 is re q uire d f or i ncl usi o n.
Rete nti o n:
Wit h gl o v e d ha n ds, t he e xa mi ner will att e mpt t o u n seat t he u p per a n d l ower de nt ure b y 
a p pl yi n g a n o p p osi n g verti cal f orce at t he ca ni ne/lateral i ncis or r e gio n of  the de nt ure.  The 
e xa mi ner will sc ore rete nti o n as 0 - 5 usi n g t he f o ll owi n g cri t eria:
5 = E xcelle nt - de nt ure offers e xcelle nt resista nce t o vert ical p ull a n d lateral f orce.
4 = Ver y  G o o d- de nt ure offers ver y g o o d resista nce t o vertical p ull a n d lateral f orce. 
3 = G o o d - de nt ure offers m o derate resista nce t o vertical p ull a n d lateral f orce.
2 = Fair - de nt ure offers m o derate resi sta nce t o vertical p ull a n d little or n o resista nce t o lateral 
f orces. 
1 = P o or - de nt ure offers sli g ht resista nce t o vertical p ull a n d little or n o resista nce t o lateral 
f orce.
0 = N o rete nti o n- w he n t he de nt ure is seate d i n place, it dis places itself. 
St a bility:
Wit h gl o v e d ha n ds, t he e xa mi ner will att e mpt t o r oc k t he seate d de nt ures b y placi n g al ter nate 
h ori z o nt al force at t he c us pi d a n d c o ntral at er al mol ar re gio n s of t he u p per a n d lo wer de nt ures.  
T he e xa mi ner will sc ore de nt ure st a bilit y as 0 - 4 usi n g t he f o ll owi n g cri t eria:
4 = E xcelle nt - w he n de nt ure base offers n o r oc ki n g o n its s u p p orti n g str uct ures u n der press ure.
3 = G o o d - w he n de nt ure base has ver y sli g ht r oc ki n g o n its s u p p orti n g str uct ures u n der 
p
ress ure.
2 = Fair - w he n de nt ure base has sli g ht r oc ki n g o n its s u p p orti n g str uct ures u n der press ure.
1 = P o or - w he n de nt ure base has m o derate r oc ki n g o n its s u p p orti n g str uct ures u n der press ure.
0 = N o sta bilit y- w he n de nt ure base has e xtre me r oc ki n g u n der press ure.
S u m sc ore ( u p per + l o wer de nt ure) of < 6 = de nt ures wit h p o or rete nti o n a n d sta bilit y. D oc u m e nt N a m e   
T y p e  V ersi o n  D oc u m e nt I d e ntifi er  Eff ecti v e D at e  
    
R e as o n F or Iss u e   
 
 
 
 
 
 
 
 
 
 
 
 
 [ADDRESS_195558]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 3 1 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195559] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: 2 2-J u n-2 0 1 7
Pa ge 3 2 of  6 2S u m  sc ore ( u p per + lo wer de nt ure) 6 -9 = de nt ures wit h fair rete nti o n a n d sta bilit y.
S u m  sc ore ( u p per + lo wer de nt ure) 1 0 -1 4 = de nt ures wit h g o o d rete nti o n a n d sta bilit y.
S u m sc ore ( u p per + l o wer de nt ure) > 1 4 = de nt ures wit h ver y g o o d rete ntio n a n d sta bili t y.
S u bject recr ui t me nt will be c o ntr olle d t o e ns ure 5 0 ± 1 0 % of t he s u bjects will be i n e a c h of t he 
l ow a n d hi g h Ka p ur -Ols ha n gr o u ps [t he l ow Ka p ur -Ols ha n gr o u p is defi ne d a s a c o m p osite 
Ka p ur -Ols ha n sc ore of  6- 1 4 (cli nicall y fair a n d g o o d de nt ures) a n d t he hi g h Ka p ur -Ols ha n 
sc ore as 1 5-1 8 (cli nicall y ver y g o o d de nt ures)].
7. 1. 4 W ell M a d e A s s e s s m e nt
Cli nic al Acce pt a bility
Eac h de nt ure ( u p per a n d l ower) will be e xa mi ne d.  O nl y de nt ures ha vi n g a de q uate (as j u d ge d 
b y a n e xa mi ner wi t h e xpert k n o wl e d ge of  pr ost h o d o ntics) verti cal di me nsi o n , free wa y s pace, 
h ori z o nt al occlusal relati ons hi ps a n d b or der e xte nsi o n will be c o nsi dere d cli nicall y 
acce pta ble.  For eac h de nt ure ( u p per a n d l ow er), t he e xa mi ner will i n dicate acce pta ble or 
u nacce pta ble o n t he C R F.
De nt ure Fi nis h a n d C o nt o ur
T he c o nt o ur a n d fi nis h of  eac h de nt ure ( ma xillar y a n d ma n di b ular) will be e xa mi ne d.  Onl y 
de nt ures wit h acce pta ble (as j u d ge d b y a n e xa mi ner wi t h e x pert k n o wle d g e of pr ost h o d o ntics) 
p or osi t y, tiss ue s urfaces, p olis he d s urfaces, c olo ur a n d t hic k ness will be acce pte d.  For eac h 
de nt ure ( u p per a n d l o wer), t he e xa mi ner will i n dicate acce pta ble or u nacce pta ble o n t he C R F.
7. 1. [ADDRESS_195560] usi n g n o de nt ure 
a d hesi ves/fi xat i ves.  De nt ures s h o uld ha ve bee n clea ne d a n d drie d b y t he st u d y st aff an d 
r e place d i n t he s u bject’s m o ut h.  Su bjects will be pr o vi de d wi t h 30 - 3 2 gra ms (accuratel y 
w ei g he d) of  no n -salte d pea n uts, di vi de d i nto s maller p orti o ns of a p pr o xi matel y ei g ht pea n ut 
hal ves b y t he st u d y  staff.  E a c h p ortio n s h o ul d be c he we d b y t he s u bject f or a p pr o xi matel y [ADDRESS_195561] will rinse t heir m o ut h 
wi t h water f or fi ve sec o n ds bef ore r e mo vi n g t heir d e nt ur e.  Su bjects will be as ke d t o r e mo ve 
t heir de nt ures (t he e xa mi ner ma y assist i n t his if re q uire d) a n d place t he m int o a l a belle d tra y 
( wit h su bject scree ni n g n u m ber) teet h side d o w n, a n d ma y r e mo ve a n y resi d ual pea n ut 
parti cles fr om t heir m o ut h wi t h water a n d a ga uze pa d ( n ot f or c ollecti o n).  The a mo u nt of 
f oo d parti cles o n eac h de nt ure will be vis uall y assesse d b y t he e xa mi ner acc or di n g t o t he scale 
bel o w a n d rec or de d i n t he C R F t o d eter mi ne if t here is e vi de nce of pea n ut parti cle mi g rati on 
u n der t he de nt ures.  T he f oll owi n g 0 – 3 assess me nt scale will be use d.  S u bjects w h o prese nt 
n o e vi de nce of  pea n ut particles u n der eit her t he u p per or l ower de nt ure (i.e. if eit her de nt ure 
sc ores as 0) will n ot be eli gi ble. 
T he l o c ati o n a n d e xte nt of  pea n ut particle mi grat i on will be rate d as f o ll ows: D oc u m e nt N a m e   
T y p e  V ersi o n  D oc u m e nt I d e ntifi er  Eff ecti v e D at e  
    
R e as o n F or Iss u e   
 
 
 
 
 
 
 
 
 
 
 
 
 [ADDRESS_195562]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 3 2 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195563] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: 2 2-J u n-2 0 1 7
Pa ge 3 3 of  6 20 = N o ne – N o  pea n ut mi grati on u n der t he de nt ure.
1 = Mi ni mal – Sl i g ht mi grati o n of pea n uts u n der t he de nt ure.
2 = M o derate – Mi grati o n of  pea n uts o ver t he i nter nal walls of t he de nt ure.
3 = E xte nsi ve – P ea n uts mi grati o n o n t he crest of t he de nt ure.
De nt ures s h o ul d be clea ne d t h or o u g hl y b y t he st u d y staff pri or t o ret ur ni n g t o t he s u bject.
7. [ADDRESS_195564] u d y 
Pr oce d ures secti o n of t his pr ot oc ol.  
7. 2. 1 F o o d O c cl u si o n T e sti n g I n c or p or ati n g D e nt ur e Di sl o d g e m e nt 
A s s e s s m e nt
F o o d Occl usi o n will be meas ure d b y a trai ne d or e x perie nce d o perat or usi n g t he met h o d 
descri be d bel o w.  6 0  5 mi n utes after t he de nt ures ha ve b ee n i nserte d:
1. T he s u bject will be i nstr ucte d t o bit e d o w n firml y o n t h ei r de nt ures.  T he s u bject will t he n 
br iefl y rinse t heir m o ut h vi g or o usl y wi t h water.  The sit e staff will r e mo v e a n y a d hesi ve 
t hat is o ozi n g fr o m t he de nt ures.  N ote: T he s u bject must n ot eat a n y f o o d d uri n g t he 6 0  5 
mi n utes wai tin g p eri o d.  S u bj e cts ma y n ot dri n k d uri n g t his 6 0  [ADDRESS_195565] y r oaste d pea n uts t o c he w a n d s wallo w.  
T he 3 2 g p orti o n of  pea n uts will be di vi de d b y t he sit e staff i n t o s maller p orti o ns of 
a p pr o xi matel y 8 pea n ut hal ves (a p pr o xi matel y 4g).  The s u bject will be as ke d t o c he w 
eac h pre -meas ure d p orti o n of  pea n uts f or at  least [ADDRESS_195566] will rinse t heir m o ut h wi t h water f or 
a p pr o xi matel y 5 sec o n ds (t o re mo ve a n y pea n ut parti cles n ot retai ne d u n der t he de nt ures).
5. T he e xa mi ner will  caref ully r e mo v e t he s u bject’s l ower de nt ure a n d pl ace it on a s mall 
t
r a y, teet h si de d o w n a n d r e mo ve a n y resi d ual a d hesi ve a n d/ or pea n ut parti cles fr om t he 
l ower g u m  with a pi [INVESTIGATOR_167770] t hat will be pl ace d i n a se parate bea ker c o de d wit h t he 
s u bject scree ni n g nu m ber, treat m e nt perio d a n d “ L” f or l o wer de nt ure.
6. T he e xa mi ner will  caref ull y re mo v e t he s u bject’s u p per de nt ure a n d pl ace it on a s mall 
tr a y, teet h si de d o w n a n d r e mo ve a n y resi d ual a d hesi ve a n d/ or pea n ut parti cles fr om t he 
r o of of t h e mo ut h wi t h a pi[INVESTIGATOR_167770] t hat will be place d i n a se parate bea ker c o de d wit h 
t he s u bject scree ni n g n u m ber, treat me nt peri o d a n d “ U” f or u p per de nt ure. D oc u m e nt N a m e   
T y p e  V ersi o n  D oc u m e nt I d e ntifi er  Eff ecti v e D at e  
    
R e as o n F or Iss u e   
 
 
 
 
 
 
 
 
 
 
 
 
 [ADDRESS_195567]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 3 3 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195568] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: [ADDRESS_195569] d i n t he c o de d bea kers wit h t he 
ga uze ( u p per a n d l o wer se paratel y ).
[ADDRESS_195570] i on 7. 2. 2 .
1 1. I n t he la b orat or y, a p pr o xi mate l y 1 0 0 ml ( or e n o u g h t o c o ver t he pr ost heses) of  hot de-
i onise d water ( 9 0 ° C, ( 1 9 4 ° F)) will be a d de d t o eac h bea ker.  The bea kers will be 
s o nicate d f or [ADDRESS_195571].
1 4. T he s ol utio ns i n t he bea kers ( mi xt ure of  water, a d hesi ve, sali va a n d pea n ut particles) will 
be heate d t o b oili n g wit h fre q ue nt stirri n g t o diss o l ve a n y u n diss ol ve d a d hesi ve.
1 5. T he h ot s ol ut i on i n eac h bea ker will be strai ne d t hr o u g h a sta n dar d testi n g sie ve, U S A # 6 0 
(c o de d wit h s u bject’s scree ni n g n u m ber, treat me nt c o de a n d U or L f or u p per a n d l ow er 
de nt ures).
1 6. T he resid ue r e mai ni n g o n t he scree n will  be was he d re peate dl y wi t h hot water t o re m o ve 
a n y a d hesi ve or sali va.
1 7. T he c ollecte d pea n ut particles will be air -drie d o ver ni g ht o n t he scree n.
1 8. T he dri e d part icles will be tra nsferre d fr o m t he scree n t o pre -w ei g he d c o de d (s u bject 
scree ni n g n u m ber, U p per/ L o wer a n d date) alu mi ni u m wei g hi n g pa ns usi n g a s pat ula a n d 
t he n will be drie d i n a n o ve n at 4 0° C ( 1 0 5° F) f or 5 h o urs.
1 9. T he pa ns will be r e mo ve d fr om t he o ve n, c o ole d t o r o o m te mperat ure a n d t he n wei g he d 
(in gra ms, t o 4 deci mal places) t o d eter mi ne t he mass of  t he part icles c o llecte d fr om eac h 
de nt ure.
Pri or t o c o m m e n ci n g t his testi n g t he su bjects will ha ve t he e ntir e f oo d occl usi o n a n d de nt ure 
di slo d ge me nt assess me nt pr oce d ure e x plai ne d t o t he m at eac h visit b y t he e xa mi ner or a 
desi g nee .  A sta n dar d scri pt will be use d t o e ns ure c o nsiste nc y i n pr oce d ures. D oc u m e nt N a m e   
T y p e  V ersi o n  D oc u m e nt I d e ntifi er  Eff ecti v e D at e  
    
R e as o n F or Iss u e   
 
 
 
 
 
 
 
 
 
 
 
 
 [ADDRESS_195572]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 3 4 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195573] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: [ADDRESS_195574] i on naire (Secti o n 1 3. 2 ) o n t heir e x perie nce d uri n g t he c he wi n g 
pr oce d ure.  The s u bject res p o nses s h o uld be tra nscri be d b y t he st u d y staff t o t he C R F.  T he 
st u d y st aff s ho ul d be mi n df ul t hat w hilst t he q uesti o n naire d oes n ot s olici t s af et y inf or m at i on,  
a n y i nf or mat i on o n safety o ut c o m es rec or de d b y s u bjects o n t he q uest i on naire s h o uld be 
e val uate d b y t he i n vesti gat or t o e ns ure all A Es are rec or de d.
7. 2. 3 D e nt ur e P h ot o gr a p h s at Tr e at m e nt Vi sit s
F or a s u bset of  su bjects, e xtra or al  di gital ph ot o gra p hs will be ta ke n of  the u n dersi de of  eac h 
de nt ure i m me diatel y aft er t heir r e mo v al  t o doc u me nt t he a p peara nce of  mi grate d particles f or 
s p o ns or re vie w.  S u bjects will be selecte d at t he discreti o n of  t he I n vesti gat or, b ut all o w f or a 
variet y of  de nt ure sizes a n d fit to be re prese nte d.  It is e x pecte d t hat a p pr o xi matel y 5 sets of 
de nt ures be p h ot o gra p he d per treat me nt gr o u p, a n d w here p ossi ble t hat c o nsiste nc y of  
s u bjects bet wee n tr e at me nts is mai ntai ne d (i.e. a s u bject will be i de ntifie d at visit 2 as bei n g 
s uita ble f or de nt ure i ma gi n g a n d will ha ve t heir de nt ures p h ot o gra p he d at visit 2, 3 a n d 4).  
S h o ul d s u bject dr o p o uts or ot her reas o ns necessitate, s u bjects ca n be s u bstit ut e d.  Di gital 
p h ot o gra p hs a n d t heir file na mes s h o uld n ot c o nt ai n a n y pers o nall y i de ntifia ble i nf or mati o n.  
T he di gi t al file s h o uld be a p pr o priatel y na me d t o i de ntif y t he s u bject scree ni n g n u m ber a n d 
t he treat me nt peri o d.  T his pr oce d ure s h o ul d be u n der ta ke n b y t he e xa mi ner or desig nee.
7. [ADDRESS_195575] u d y  Pr oce d ures
secti on of t his pr ot oc ol.  
7. 3. 1 Or al S oft Ti s s u e ( O S T) E x a mi n ati o n - E d e nt ul o u s
T he O S T e xa mi nat i on s h o uld be p erf or m e d b y a q ualifie d de nt ist an d i deall y t he sa me 
e xa mi ner s h o uld be use d T he O S T E xa m -E de nt ul o us will i ncl u de t he la bial m uc osa 
(incl u di n g li ps), b uccal m uc osa, t o n g ue, gi n gi val m uc osa, s u bli n g ual area, har d a n d s oft 
p al ates, m uc o gi n gi val f ol ds, s u b ma n di b ular area, sali var y gla n ds, t o nsilar a n d p har y n geal 
areas.  Obser vat i ons will be ma de of  an y er yt he ma, des q ua mat i on a n d ulcerat i ons, a n d ot h er 
r ele va nt cli nical o bser vati o ns.  The res ults of  t he e xa mi nat i on will be rec or de d i n t he C R F as 
eit her n or m al or a b n or mal.  The l ocat i on a n d br ief descri pt i on of  an y a b n or malities will als o 
be rec or de d.
7. 3. [ADDRESS_195576]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 3 5 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195577] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: [ADDRESS_195578] u d y p eri o d ( or w he n p ot e nti al pre g na nc y is ot h er wise s us pecte d). Pre g na nc y tests 
ma y als o be re peate d as per re q uest of I R Bs/ E Cs or if re q uire d b y l ocal re g ula tio ns.
I n t he case of a p osi tive c o nfir me d pre g na nc y , t he s u bject will be wi t hdra w n fr o m 
a d mi nistrati o n of i n vest i gati onal pr o d uct a n d fr o m t he st u d y .
If a uri ne sa m ple is c ollecte d as part of t he pre g na nc y testi n g it will be dis p ose d of 
i m me diatel y aft er t he c o nclusi o n  of t he test
[ADDRESS_195579] or me dical de vice.
N O T E: A n A E ca n t heref ore be a n y u nfa v o ura ble a n d u ni nte n de d si g n (i ncl u di n g a n a b n or mal 
la b orat or y fi n di n g), s y m pt o m, or dis e as e ( ne w or e xacer bate d) te m p orall y ass o ciate d wi t h t he 
use of a st u d y  tr e at me nt.
E ve nts Meeti n g t he A E Defi niti o n:  
 A n y a b n or mal safet y assess me nts (e. g., O S T fi n di n gs, i ncl u di n g t hose t hat w o rse n 
fr om baseli ne, c o nsi dere d cli nicall y si g nifica nt i n t he me d ical a n d scie ntific j u d g me nt 
of  t he i n vesti gat or (ie, n ot relate d t o pr o gressi o n of u n derl yi n g disease)).
 E xacer bat i on of  a chr o nic or i nter mitte nt pre -e xisti n g c o n ditio n  incl u di n g eit her a n 
i ncrease i n fre q ue nc y a n d/ or i nte nsit y of  t he c o n ditio n .
 Ne w c o n ditio ns detecte d or dia g n ose d aft er st u d y treat me nt a d mi nistrati o n e ve n 
t ho u g h it m a y ha ve bee n prese nt bef ore t he start of t he st u d y.
 Si g ns, s y m pt o ms, or t he cli nical se q uelae of a s us pecte d dr u g -dr u g i nteracti o n .
 Si g ns, s y m pt o ms, or t he cli nical se q uelae of  a sus pecte d o ver d ose of  either st u d y 
treat me nt or a c o nc o mita nt me d icati on. O ver d ose per se will n ot be re p orte d as a n 
A E/ S A E u nless it  is a n i nte ntio nal o ver d ose ta ke n wi t h p ossi ble s uici dal/self-har mi n g 
i nte nt . S uc h o ver d oses s h o ul d be re p orte d re gar dless of se q uelae.
 " Lac k of efficac y" or "f ail ure of  ex pecte d p har m a c olo gi cal act i on" per se will n ot be 
re p orte d as a n A E or S A E. S uc h i nsta nces will be ca pt ure d i n t he efficac y 
assess me nts. H o we ver, t he si g ns, sy m pt o m s, a n d/ or cli nical se q uelae res ultin g fr om 
lac k of efficac y will be re p orte d as A E or S A E if t he y f ulfil t he defi nitio n of  a n AE or 
S A E. 
E ve nts N O T meeti n g t he A E defi niti o n:  D oc u m e nt N a m e   
T y p e  V ersi o n  D oc u m e nt I d e ntifi er  Eff ecti v e D at e  
    
R e as o n F or Iss u e   
 
 
 
 
 
 
 
 
 
 
 
 
 [ADDRESS_195580]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 3 6 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195581] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: 2 2-J u n-2 0 1 7
Pa ge 3 7 of  6 2 A n y cli nicall y si g nifica nt a b n or mal la b orat or y fi n di n gs (if a p plica ble) o r ot her 
a b n or mal safet y assess me nts w hic h are ass o ciate d wi t h the u n derl yi n g disease, u nless 
j u d ge d b y t he i n vesti gat or t o be m ore se vere t ha n e x pecte d f or t he s u bject’s c o n diti on. 
 T he disease/ dis or der bei n g st u di e d or e x p e ct e d pr o gr essio n, si g ns, or s y m p t o ms of t he 
di sease/ dis or der bei n g st u die d, u nless m o re se vere t ha n e x pecte d f or t he s u bject’s 
c o n ditio n. 
 Me dical or s ur gical pr oce d ure (e. g., e n d osc o p y, a p pe n dect o m y) is n ot t he A E. T he 
c o n ditio n t hat l ea ds t o t he pr oce d ure is a n A E (e. g., a p pe n dicit is).
 Si t u atio ns w here a n u nt o war d me d ical occ urre nce di d n ot occ ur (s ocial a n d/ or 
c o n ve nie nce a d missi o n t o a h os pi[INVESTIGATOR_307]).
 A nt ici pate d d a y -t o-d a y  fl uct uatio ns of  pr e-e xist i n g di sease(s) or c o n dit i on(s) prese nt 
or detecte d at t he start of t he st u d y  t hat d o n ot w orse n. 
8. 1. 2 S eri o u s A d v er s e E v e nt
If a n e ve nt is n ot a n A E per defi ni tio n  ab o ve, t he n it ca n n ot be a n S A E e ve n if serio us 
c o n ditio ns are met (e. g., h os pi[INVESTIGATOR_148495] i on f or si g ns/s y m pt o ms of  t he disease u n der st u d y, d e at h 
d ue t o pr o gressi o n of disease).
A seri o us a d v erse e ve nt is a n y u nt o war d me dical occ urre nce at a n y d ose t hat:
 Res ults i n de at h
 Is life-t hre ate ni n g
 T he t er m 'life-t hreate ni n g' i n t he defi ni tio n of  'seri o us' r efers t o a n eve nt i n w hic h 
t he partici pa nt was at ris k of  deat h at t h e ti me of  t he e ve nt. It d oes n ot refer t o a n 
e ve nt, w hic h h y p ot heticall y mi g ht ha ve ca use d deat h, if it were m ore se vere;
 Re q uires i n p atie nt h os pit alis ati o n or pr ol o n g ati o n of e xisti n g h os pit alis ati o n
 I n ge neral , h os pi [INVESTIGATOR_167771] g nifies t hat t h e parti ci pa nt has bee n detai ne d ( us uall y 
i n v ol vi n g at least a n o ver ni g ht st a y) at t he h os pi t al or e mer ge nc y war d f or 
o bser vat i on a n d/ or treat me nt t hat w o ul d n ot ha ve bee n a p pr o priate i n t he 
p h ysicia n’s of fice or o ut pati e nt setti n g. C o m plicat i ons t hat occ ur d uri n g 
h os pi [INVESTIGATOR_167772] A E. If a c o mplicati o n pr o l on gs h os pi [INVESTIGATOR_167773] f ulfils a n y 
ot her serio us crit eria, t he e ve nt is serio us. W he n i n d o u bt as t o w het her 
“ h os pi[INVESTIGATOR_148495] i on” occ urre d or was necessar y , t he A E s h o uld be c o nsi dere d seri o us.
 H os pi[INVESTIGATOR_148495] i on f or elect i ve treat me nt of a pre -e xisti n g c o n dit i on t hat di d n ot 
w orse n fr o m baseli ne is n ot c o nsi dere d a n A E.
 Res ults i n persiste nt or si g nific a nt dis a bilit y/i nc a p acit y
 T he t er m disa bilit y mea ns a s u bsta ntial disr u pt i on of  a pers o n’s a bilit y t o c o nd uct 
n or m al lif e fu nct i ons.
 T his d ef i niti on is n ot i nte n de d t o i ncl u de e x perie nces of  relati vel y mi n or me d ical 
sig nifica nce s uc h as u nc o m p licate d hea dac he, na usea, v o mit i n g, di arr h oea,  D oc u m e nt N a m e   
T y p e  V ersi o n  D oc u m e nt I d e ntifi er  Eff ecti v e D at e  
    
R e as o n F or Iss u e   
 
 
 
 
 
 
 
 
 
 
 
 
 [ADDRESS_195582]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 3 7 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195583] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: 2 2-J u n-2 0 1 7
Pa ge 3 8 of  6 2i nfl ue nza, a n d acci de ntal tra u ma (e. g., s prai ne d a n kle) w hic h ma y i nterfere wit h or 
pre ve nt e ver y d a y  lif e fu nct i ons b ut d o n ot c o nstit ute a s u bsta nt ial disr u pti o n
 Res ults i n c o n ge nit al a n o m al y/ birt h defect
 Ot her sit u ati o ns
 Me dical or scie nt ific j u d g me nt s h o uld be e xercise d i n deci di n g w het her S A E 
re p orti n g is a p pr o priate i n ot h er sit u atio ns s uc h as i m p orta nt me dical e ve nts t hat 
ma y n ot be i m me diatel y life-t hreate ni n g or res ul t i n deat h or h os pi [INVESTIGATOR_148500] b ut 
ma y je o par dize t he parti ci pa nt or ma y re q uire me di cal or s ur gical i nter ve nt i on t o 
pre ve nt o ne of  the ot h er o utc o m es liste d i n t he a b o ve defi ni tio n . T hese e ve nts 
s h o uld us uall y be c o nsi dere d seri o us.
 E xa m ples of  suc h e ve nts i ncl u de i n vasi ve or ma li g na nt ca ncers, i nte nsi ve 
treat me nt i n a n e mer ge nc y r o o m or at h o me f or aller gic br o nc h os pas m, bl o o d 
d y scrasias or c o n v ulsi o ns t hat d o n ot res ult i n h os pi [INVESTIGATOR_148500], or de vel o p me nt of 
dr u g de pe n de nc y  or dr u g a b use.
8. [ADDRESS_195584] or y / C urre nt Me dical C o n dit i ons sect i on 
of  t he case re p ort f or m ( C R F) n ot t he A E secti on.
8. 2. 2 S eri o u s A d v er s e E v e nt
S A Es assesse d as rel ate d t o stu d y pa rtici pat i o n (e. g., i n vesti gati onal pr o d uct, pr ot oc ol 
ma n date d pr oce d ures, i n vasi ve tests, or c ha n ge i n e xist i n g t hera p y) or relate d t o a G S K 
c o nc o mita nt me d icati on will be rec or de d fr om t he ti me a s u bject pr o vi des i nf or me d c o nse nt, 
w hic h is o btai ne d pri or t o t he s u bject’s partici pat i o n i n t he st u d y, i. e., prior t o u n der g oi n g a n y 
st u d y-relate d pr oce d ure a n d/ or recei vi n g i n vesti gatio nal pr o d uct a n d u ntil [ADDRESS_195585] u d y partici p ati o n  (e. g., i n vesti gati onal pr o d uct, pr ot oc ol 
ma n date d pr oce d ures, i n vasi ve tests, or c ha n ge i n e xist i n g t hera p y) or n ot relate d t o a G S K 
c o nc o mita nt me d icatio n will be rec or de d fr om t he ti me t he s u bjects pr o vi des i nf or me d 
c o nse nt a n d u nt il [ADDRESS_195586]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 3 8 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195587] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: [ADDRESS_195588] i one d a b o ut A Es. 
Eac h A E is t o be assesse d t o deter mi ne if it  meets t he criteria f or S A Es.  If a n S A E occ urs, 
e x pe dite d re p orti n g will f o ll ow l ocal a n d i nter nat i onal re g ulat i ons, as a p pr o priate.
W he n a n A E/ S A E occ urs, it  is t he res p o nsi bility of  the i n vesti gat or t o re vie w all 
d oc u m e nt atio n (e. g., h os pi t al pr o gress n otes, la b orat or y, a n d dia g n ostics re p orts) relate d t o t he 
e ve nt.
T he i n vesti g at or or si te staff will t he n rec or d all rele va nt i nf or matio n re gar di n g a n A E/ S A E i n 
t he C R F.
It is n ot acce pta ble f or t he i n vesti gat or t o se n d p h ot oc o pi [INVESTIGATOR_167774]’s me dical 
rec or ds t o G S K i n lie u of c om p leti o n of t he G S K / A E/ S A E C R F pa ge.
T here ma y be i nsta nces w he n c o pi[INVESTIGATOR_167775] f or cert ai n cases are re q ueste d b y 
G S K.  I n t his i nsta nce, all s u bject i de nt ifiers, wit h t he e xce pti on o f t he s u bject n u m ber, will be 
bli n de d o n t he c o pi[INVESTIGATOR_1309] t he me dical rec or ds pri or t o s u b missi o n t o G S K.
T he i n vesti gat or will att e mpt t o esta blis h a di a g n osis of t he e ve nt base d o n sig ns, s y m pt o ms, 
a n d/ or ot her cli nical i nf or mati o n.  In s uc h cases, t he di a g n osis will be d o c u m e nte d as t he 
A E/ S A E a n d n ot t he i n di vi d ual si g ns/s y m pt o ms. Cli nical A E s will be descri be d b y dia g n osis 
a n d n ot b y s y m pt o ms w he n p ossi ble (e. g., u p per res pir at or y tract i nfecti on, seas o nal aller g y, 
etc. i nstea d of r u n n y n ose).
Me dical c o n ditio n s re p orte d pri or t o t he ti me p eri o d f or re p orti n g A Es/ S A Es s h o uld be 
rec or de d as part of t he s u bject’s me dical hist or y.
A Es elicite d b y t he i n vesti gat or in a sta n dar d ma n ner at t he st u d y visits s h o uld als o b e 
rec or de d i n t he A E secti on of  the C R F. Care will be ta ke n n ot t o i ntr o d uce bias w he n 
detecti n g A E a n d/ or S A E. O pe n -e n de d a n d n o n- lea di n g ver bal q uest i oni n g of  the partici pa nt 
is t he preferre d met h o d t o i n q uire a b o ut A E occ urre nce.
8. 3. 1 A d v er s e E v e nt
All A Es will be re p orte d o n t he A E pa ge(s) of  the C R F b y t he i n vesti gat or or sit e staff.  It 
s h o uld be n ote d t hat t he f or m for c o llecti on of S A E i nf or mati on is n ot t he sa me as t he A E  
C R F.  Where t he sa me data are c ollecte d, t he f or ms m u st be c o m p lete d i n a c o nsiste nt 
ma n ner.  For e xa m ple, t he sa me A E t er m sh o ul d be use d o n b ot h f or ms.  AE s h o uld be 
re p orte d usi n g c o ncise me dical ter mi n ol og y o n t he C R F as well as o n t he f or m for c oll e cti o n 
of  S A E i nf or mat i on.
8. 3. 2 S eri o u s A d v er s e E v e nt
A pa per c o p y of t he S A E f or m pr o vi de d i n t he i n vesti gat or stu d y master file s h o uld be 
c o mplete d as f ull y as p ossi ble. 
It is esse ntial t o e nter t he f oll o wi n g i nf or mati on:  D oc u m e nt N a m e   
T y p e  V ersi o n  D oc u m e nt I d e ntifi er  Eff ecti v e D at e  
    
R e as o n F or Iss u e   
 
 
 
 
 
 
 
 
 
 
 
 
 [ADDRESS_195589]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 3 9 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195590] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: 2 2-J u n-2 0 1 7
Pa ge 4 0 of  6 2 Pr ot oc ol  a n d s u bject ide nt ifiers
 S u bject’s de m o gra p h y
 Descri pt i on o f e ve nts, wit h dia g n osis if a vaila ble
 I n vesti gat or o pi [INVESTIGATOR_167776] o ns hi p t o st u d y  pr o d uct 
 Cri t erio n f or s eri o us ness.
T he f oll owi n g are desira ble a n d are of  partic ul ar rele va nce f or i n vesti gat or a n d G S K C H 
assess me nt of t he S A E re p ort:
 Date of o nset of A E 
 Date A E st o p pe d, if rele va nt
 St u d y  pr o d uct start date
 St u d y  pr o d uct e n d date if rele va nt
 Act i on ta ke n o n st u d y  pr o d uct
 O utc o m e if k n o w n
T he S A E f or m, c o m p lete d as f ull y as p ossi ble, m ust be e- ma ile d t o t he G S K C H Cli nical 
O perati o ns Sa fety Re p orti n g e mail b o x wi t h the st u d y nu m ber a n d s u bject n u m ber i n t he 
s u bject li ne of  the e mail i m me di atel y a n d u n der n o circ u mst a nce s h o ul d t his e xcee d [ADDRESS_195591] u d y Ma na ger s h o uld als o be n otifie d of  the 
sit u atio n b y  t ele p h o ne or e mail.
E m ail Seri o us A d verse E ve nts t o:
T h e G S K C H St u d y  M a n a g er or d esig n e e will  be res p o nsi ble f or f or war di n g t he S A E f or m t o 
t he Case Ma na ge me nt Gr o u p, Gl o bal Cli nical S af et y a n d P h ar mac o vi gila nce mail b o x 
T he i nitial re p ort will be f oll owe d u p wi t h mor e i nf or mat i on as rele va nt, or as re q ueste d b y 
t he G S K C H st u d y ma na ger.
8. 3. 3 S p o n s or’ s R e p orti n g R e q uir e m e nt s t o R e g ul at or y A ut h oriti e s a n d 
Et hi c s C o m mitt e e s
G S K has a le gal res p o nsi bility t o n otif y, as a p pr o priate, t he l ocal re g ulat or y aut h ori t y an d 
ot her re g ul at or y a ut h orities a b o ut t h e s af et y of a pr o d uct u n der cli nical i n vesti gati on.  Pr o m pt  D oc u m e nt N a m e   
T y p e  V ersi o n  D oc u m e nt I d e ntifi er  Eff ecti v e D at e  
    
R e as o n F or Iss u e   
 
 
 
 
 
 
 
 
 
 
 
 
 [ADDRESS_195592]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 4 0 of 6 2P P D
P P D
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195593] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: [ADDRESS_195594] y wi t h c o u ntr y specific re g ulat or y re q ui r e m e nts r elat i n g t o s afet y re p orti n g t o 
t he re g ulat or y a ut h orit y, I R B/ E C a n d i n vesti gat ors.
I n vesti gat or safety re p orts m u st be pre pare d f or s us pecte d u ne x pecte d serio us a d verse 
reactio ns ( S U S A R) acc or di n g t o l ocal re g ulat or y re q uire me nts a n d s p o ns or p olic y a n d 
f or war de d t o i n vesti gat ors as necessar y.
A n i n vesti gat or w h o recei ves a n i n vesti gat or safet y r e p ort descri bi n g a S A E or ot h er s pecific 
safety i nf or mati o n e. g., s u m mar y or listi n g of S A E) f r o m t he s p o ns or will re vie w a n d t he n file 
it alo n g wi t h t he I n vesti gat or’s Br oc h ure a n d will n otif y t he I R B/I E C, if a p pr o priate acc or di n g 
t o lo c al  r e q uire me nts.
8. [ADDRESS_195595] u d y a n d will assig n i t t o o ne of t he f oll o wi n g cate g ories:
 Mil d:  A n e ve nt t hat i s easil y t olerate d b y t he s u bject, ca usi n g mi ni mal disc o mf ort a n d 
n ot i nterferi n g wit h e ver y da y act i vities.
 M o derate:  An e ve nt t hat is s ufficie ntl y disc o mf orti n g t o i nterfere wi t h nor m al 
e ver y da y act i vities
 Se vere:  A n e ve nt t hat pre ve nts n or mal e ver y da y acti vit ies. 
N ote: A n A E t hat is as sesse d as se vere will  not be c o nf use d wi t h an S A E. Se verit y is a 
cate g or y utilise d f or rati n g t he i nte nsit y of a n e ve nt; a n d b ot h A Es a n d S A Es ca n be assesse d 
as se vere. F or e xa m ple, a hea dac he ma y be se vere (i nterferes si g nifica ntl y wi t h the s u bject's 
us u al fu nct i on) b ut w o ul d n ot be classifie d as s erio us u nless it met o ne of  the criteria f or 
S A Es, liste d a b o ve. 
8. 4. 2 C a u s alit y A s s e s s m e nt
T he ca usalit y assess me nt is o ne of  the criteria use d w he n deter mi ni n g re g ulat or y re p ortin g 
re q uire me nts. F or eac h A E/ S A E, t he i n vesti gat or m ust d o c u m e nt i n t he me dical n otes t hat 
he/s he has re vie we d t he A E/ S A E a n d has pr o vi de d a n assess me nt of  ca usalit y. T h e 
i n vesti gat or’s assess me nt of ca usalit y must be pr o vi de d f or all A Es (seri o us a n d n o n- serio us); 
t he i n vest i gat or m ust rec or d t he ca usal relati ons hi p i n t he C R F, as a p pr o priate, a n d re p ort s uc h 
a n assess me nt i n acc or da nce wit h t he S A E re p orti n g re q uire me nts if a p plica ble.
A "reas o na ble p ossi bilit y" of  a relatio ns hi p c o n ve ys t hat t here are facts, e vide nce, a n d/ or 
ar g u me nts t o s u g gest a ca usal r elat i ons hi p, rat her t ha n a relati ons hi p ca n n ot be r ule d o ut. 
Ge nerall y, t he facts (e vi de nce) or ar g u me nts t o s u g gest a ca usal relatio ns hi p s h o uld be 
pr o vi de d. D oc u m e nt N a m e   
T y p e  V ersi o n  D oc u m e nt I d e ntifi er  Eff ecti v e D at e  
    
R e as o n F or Iss u e   
 
 
 
 
 
 
 
 
 
 
 
 
 [ADDRESS_195596]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 4 1 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195597] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: 2 2-J u n-2 0 1 7
Pa ge 4 2 of  6 2T he i n vesti gat or will use cli nical j u d g me nt t o deter mi ne t he relatio ns hi p a n d will als o c o ns ult 
t he I n vesti gat or Br oc h ure (I B), Safet y St at e m e nt a n d/ or Pr o d uct I nf or mati on, f or mar kete d 
pr o d ucts, i n t he deter mi nat i on of  his/ her assess me nt.  Alt er nati ve ca uses, s uc h as u n derl yi n g 
di sease(s), c o nc o mit a nt t hera p y, ot her ris k fact ors, a n d t he t e mp or al  relat i ons hi p of  the e ve nt 
t o t he st u d y pr o d uct will be c o nsidere d a n d i n vest i gate d.
T here ma y be sit u atio ns w he n a n S A E has occ urre d a n d t he i n vesti gat or has mi ni ma l 
i nf or mat i on t o i ncl u de i n t he i nitial re p ort t o G S K.  H o we ver, it is ver y i m p ort a nt t h at t he 
i nvesti g at or al w a ys m a ke a n assess me nt of c a us alit y f or e ver y e ve nt p r i or t o t he i niti al 
tr a ns missi o n of t he S A E d at a t o G S K. T he i n vesti gat or ma y c ha n ge his/ her o pi [INVESTIGATOR_9384] o n of  
ca usalit y i n li g ht of f oll o w-u p i nf or mat i on a n d se n d a n S A E f oll o w -u p re p ort wi t h t he u p date d 
ca usalit y assess me nt. 
8. [ADDRESS_195598] will be f oll owe d t o deter mi ne t he o ut c o m e of  the pre g na nc y. I nfor m at i on o n t he 
stat us of  t he m o t her a n d i nfa nt / ne o nate (incl u di n g c o nc o mit a nt me d icatio ns ta ke n b y t he 
m o t her d uri n g t he pre g na nc y) will be f or war de d b y t he i n vesti gat or t o t he G S K C H Cli nical 
O perati o ns Safet y Re p orti n g e mail bo x a n d t he G S K C H St u d y  Ma na ger or desi g nee will 
f or war d t his i nf or mat i on t o t he Case Ma na ge me nt Gr o u p, Gl o bal Cli nical S af et y a n d  D oc u m e nt N a m e   
T y p e  V ersi o n  D oc u m e nt I d e ntifi er  Eff ecti v e D at e  
    
R e as o n F or Iss u e   
 
 
 
 
 
 
 
 
 
 
 
 
 [ADDRESS_195599]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 4 2 of 6 2P P D
P P D
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195600] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: 2 2-J u n-2 0 1 7
Pa ge 4 3 of  6 2P har mac o vi gila nce gr o u p ma il b ox at G S K . Ge nerall y, foll o w -u p will 
be n o l on ger t ha n 6 t o 8 w e e ks f oll owi n g t he esti mated deli ver y date. A n y ter mi nati on of  t he 
pre g na nc y will be re p orte d.
W hile pre g na nc y it self is n ot c o nsi dere d t o be a n A E, a b n or mal pre g na nc y  outc o mes (e g, 
s p o nta ne o us a b ortio n, f oet al deat h, still birt h, c o n ge nital a n o ma lies, e ct o pic pre g na nc y) are 
c o nsi der e d t o be a n d s h o ul d be rec or de d as a n S A E.
A n y fe male part ici pa nt w h o bec o mes pre g na nt w hile partici pati n g will be with dra w n fr o m t he 
st u d y.
8. [ADDRESS_195601]’s c o n dit i on.
All A E s/ S A Es will be f oll owe d u nt il res ol uti on, u ntil t he c o n dit i on sta bilises, u ntil t he e ve nt is 
ot her wi se e x plai ne d, or u ntil t he s u bject is l ost t o f oll o w-u p.  
T he i n vesti gat or is o bli gate d t o perf or m or arra n ge f or t he c o n d uct of  su p ple me ntal 
meas ure me nts a n d/ or e val uati o ns as ma y be i n dicate d or as re q ueste d b y G S K t o eluci date as 
f ull y as p ossi ble t he nat ure a n d/ or ca usalit y of  the A E or S A E. T his ma y incl u de a d ditio n al 
la b orat or y tests or i n vesti gati ons, hist o pat h ol o gi c al  exa mi nat i ons, or c o ns ultati o n wi t h ot her 
healt h care pr ofessi o nals.
Ne w or u p date d i nf or mat i on will be rec or de d i n t he ori gi nall y c o m p lete d C R F.
T he i n vesti gat or will s u b mit a n y u p date d S A E data t o G S K wi t hi n [ADDRESS_195602]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 4 3 of 6 2P P D
P P D
P P D
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195603] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: [ADDRESS_195604] i on or deteri orati o n i n t he c haracteristics a n d/or 
perf or m a nce of  a d e vi c e as well as a n y i na de q uac y i n t he la belli n g or t h e i nstr uctio ns f or use 
w hic h, di rectl y or i n directl y, mi g ht lea d t o or mi g ht ha ve le d t o t he deat h of  a 
parti ci pa nt/ user/ ot her pers o n or t o a seri o us deteri orati o n i n his/ her state of  healt h.
N ot all i nci de nts lea d t o deat h or seri o us d et eri orati o n i n healt h. T he n o n-occ urre nce of s uc h a 
res ult mi g ht ha ve bee n d ue t o ot her f ort u nate cir c u msta nces or t o t he i nter ve nti o n of  healt h 
care pers o n nel.
It is s ufficie nt t h at:
 A n i nci de nt associate d wi t h a de vice ha p pe ne d a n d
 T he i nci de nt was s uc h t hat, if it occ urre d a gai n, mi g ht lea d t o deat h or a seri o us 
deteri or ati o n i n healt h.
A seri o us deteri orati o n i n state of healt h ca n i ncl u de a n y  of t h e fol l owi n g:
 Life -t hreate ni n g ill ness
 P er m a ne nt im pair me nt of b o d y  fu ncti o n or per m a ne nt da ma ge t o b o d y str uct ure
 C o n di tio n necessitat i n g me d ical or s ur gical i nter ve nt i on t o pre ve nt o ne of t he a b o ve 
 F oetal  distress, f oetal deat h, or a n y c o n ge nit al a b n or malit y or bi rt h defects
E x a m ples of i nci de nts:
 A p artici pa nt, user, care gi ver, or healt hcare pr ofessi o nal is i nj ure d as a res ult of a 
me dical de vice fail ure or its mis use.
 A partici pa nt’s st u d y  tr e at me nt is i nterr u pte d or c o m pr o mise d b y a me dical de vice 
fail ure.
 A mis dia g n osis d ue t o me dical de vice fail ur e lea ds t o i na p pr o priate treat me nt.
 A partici pa nt’s healt h deteri orates d ue t o me dical de vice fail ure.
8. 8. 2 R e p orti n g of a n I n ci d e nt s a n d M alf u n cti o n s
 All i nci de nts m ust be re p orte d t o G S K wit hi n 2 4 h o urs ( or s o o ner if p ossi ble) of 
t he i n vesti g at or or desi g nee bec o mi n g a w are of t he sit u ati o n.
 A n y me dical de vice i nci de nt occ urri n g d uri n g t he st u d y will be d oc u me nte d i n t he 
s u bject's me dical rec or ds, i n acc or da nce wi t h the i n vesti gat or's n or m al cli nical 
practi ce, a n d o n t he a p pr o priate I nci de nt Re p ort F or m .  In a ddi tio n, f or i nci de nts 
f ulfilli n g t he defi nit i on of a n A E  or a n S A E, t he a p pr o priate A E C R F pa ge or S A E 
f or m will be c o mplete d a n d re p orte d as per t he A E a n d S A E re p orti n g secti o ns. D oc u m e nt N a m e   
T y p e  V ersi o n  D oc u m e nt I d e ntifi er  Eff ecti v e D at e  
    
R e as o n F or Iss u e   
 
 
 
 
 
 
 
 
 
 
 
 
 [ADDRESS_195605]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 4 4 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195606] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: 2 2-J u n-2 0 1 7
Pa ge 4 5 of  6 2 T he I nci de nt Re p ort F o r m will be c o m p lete d as t h or o u g hl y as p ossi ble a n d si g ne d b y 
t he i n vesti gat or bef ore tra ns mittal t o G S K C H.  It is v er y  im p orta nt t hat t he 
i n vesti gat or descri bes a n y c orrecti ve or re me dial actio ns ta ke n t o pre ve nt rec urre nce of 
t he i nci de nt.
 T he c o m p lete d I nci de nt Re p ort F or m  sh o ul d be e maile d t o t he G S K C H Cli nical 
O perati o ns Safet y Re p orti n g e mail b o x wi t h the st u d y nu m ber a n d s u bject n u m ber i n 
t he s u bject li ne of t he e mail as s o o n as p ossi ble, b ut n ot l ater t h a n [ADDRESS_195607]’s rec or ds.
 T he G S K C H St u d y  Ma na ger s h o uld be n otifie d of t he sit uati o n b y  t ele p h o ne or e mail.
E m ail t he I nci de nt Re p ort F or ms t o:
 T he G S K C H St u d y  Ma na ger or desi g nee will be res p o nsi ble f or f or war di n g t he 
I nci de nt Re p ort F or m t o t he Case Ma na ge me nt Gr o u p, Gl o bal Cli nical Safet y a n d 
P har mac o vi gila nce gr o u p ma il b ox , res p o nsi ble f or t he st u d y 
a n d ot her G S K C H pers o n nel as a p pr o priate.
 T he i nitial re p ort will be f oll o we d u p wi t h mor e i nf or mati on as rele va nt, or as 
re q ueste d b y t he G S K C H st u d y ma na ger.
T he i n vesti gat or will f oll o w t he f oll owi n g dir e cti o ns re gar di n g t he re p orti n g of  a de vice 
fail ure ( malf u ncti on):
 N otif y G S K C H i m me diatel y ( b y  fol l owi n g t he pr ocess descri be d a b o ve).
 Sc he d ule t he s u bject t o ret ur n t o t he site pr o m pt l y t o ret ur n t he faile d de vice.
 Rec or d a n y i nci de nts o n t he C R F a n d I nci de nt Re p ort F or m  fol l owi n g i nstr uctio ns 
gi ve n i n t he sect i on a b o ve.
 Ret ur n t he faile d de vice t o t he s p o ns or as s o o n as p ossi ble, i ncl u di n g d oc u me ntati o n of 
t he details of t he fail ure 
8. 8. 3 F oll o w -u p of M e di c al D e vi c e I n ci d e nt s
 All me dical de vice i nci de nts i n v o l vi n g a n A E will be f oll owe d a n d re p orte d i n t he 
sa me ma n ner as ot her A Es. T his a p plies t o all partic i pa nts, i ncl u di n g t h ose w h o 
di sc o nti n ue st u d y tr e at me nt or t he st u d y.
 T he i n vest i gat or is res p o nsi ble f or e ns uri n g t hat f oll o w-u p i ncl u des a n y s u p ple me ntal 
i n vesti gati ons as i n dicate d t o el uci date t he nat ure a n d/ or ca usalit y of  t he i nci de nt.
 Ne w or u p date d i nf or mati o n will  be rec or de d o n t he ori gi nall y c o m p lete d f or m with 
all c ha n ges si g ne d a n d date d b y t he i n vesti gat or. D oc u m e nt N a m e   
T y p e  V ersi o n  D oc u m e nt I d e ntifi er  Eff ecti v e D at e  
    
R e as o n F or Iss u e   
 
 
 
 
 
 
 
 
 
 
 
 
 [ADDRESS_195608]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 4 5 of 6 2P P D
P P D
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195609] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: 2 2-J u n-2 0 1 7
Pa ge 4 6 of  6 28. 8. 4 R e g ul at or y a n d Et hi c s R e p orti n g R e q uir e m e nt s f or I n ci d e nt s
 I n or der t o f ulfil re g ulat or y re p orti n g o bli gati o ns w orl d wi de, t he i n vesti gat or is 
res p o nsi ble f or t he detecti o n a n d d oc u me ntati o n of  eve nts meet i n g t he defi nit i ons of  
i nci de nt or ma lf u ncti o n t hat o c c ur d uri n g t he st u d y wi t h suc h de vices. Me dical de vice 
i nci de nts or malf u nct i ons of t he de vice t hat res ult i n a n i nci de nt will be detecte d, 
d oc u m e nte d, a n d re p orte d d uri n g all p eri o ds of  t h e st u d y in w hic h t he me dical de vice 
is use d. 
 T he i n vest i gat or will pr om pt l y re p ort all i nci de nts occ urri n g wit h a n y me dical de vice 
pr o vi de d f or use i n t he st u d y  in or der f or t he s p o ns or t o f ulfil t he le gal res p o nsi bilit y t o 
n otif y a p pr o priate re g ulat or y  a ut h orities a n d ot her e ntities a b o ut certai n safety 
i nf or mat i on rel at i n g t o me dical de vices bei n g use d i n cli nical st u dies.
 T he i n vesti gat or, or res p o nsi ble pers o n acc or di n g t o lo c al  re q uire me nts (e. g., t he hea d 
of  the me dical i nstituti o n), will c o mpl y wi t h the a p plica ble l ocal re g ulat or y 
re q uire me nts relat i n g t o t he re p orti n g of i nci de nts t o t he I R B/I E C.
[ADDRESS_195610] e m.
9. 1 S o ur c e D o c u m e nt s/ D at a
T he s o urce d oc u m e nts (e. g., h os pi t al rec or ds, cli nical a n d of fice c harts, lab orat or y n otes, 
me m ora n da, s u bjects’ diari es or e v al u atio n c hec klists, p har m ac y dis pe nsi n g rec or ds, rec or de d 
data fr o m a ut o mate d i nstr u me nts, micr ofic hes, p h ot o gra p hic ne gati ves, micr ofil m or ma g netic 
me dia, x- ra ys, s u bject files a n d rec or ds ke pt at  the p har mac y , at t he lab orat or y  an d at t he 
me dic o -tec h nical de part me nts i n v ol ve d i n t he cli nical st u d y) w hi c h c o nt ai n t h e s o ur c e of d ata 
rec or de d i n t he C R F s h o uld be s pecifie d i n Sect i o n [ADDRESS_195611] w h o h as gi ve n i nf or me d c o nse nt/asse nt a n d has bee n scree ne d, C R F m u st b e 
c o mplete d a n d si g ne d b y t h e Pri n ci p al I n v esti gat or ( or a ut h orise d desi g nee) t o certif y t hat t he 
data are c o m plete a n d c orrect.   D oc u m e nt N a m e   
T y p e  V ersi o n  D oc u m e nt I d e ntifi er  Eff ecti v e D at e  
    
R e as o n F or Iss u e   
 
 
 
 
 
 
 
 
 
 
 
 
 [ADDRESS_195612]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 4 6 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195613] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: [ADDRESS_195614] t he pri vac y of  su bjects, n o Pers o nall y I d ent ifia ble I nf or matio n ( PII) 
(incl u di n g t he s u bject's na me or i nitials or f ull birt h date) is t o be rec or de d i n t he C R F or as 
part of t he q uer y  te xt.
All C R F pa ges s h o uld be c o m p lete d d uri n g a s u bject assess me nt w he n t he C R F has bee n 
desi g nate d as t he s o urc e.  Data t hat is s o urce d else w here s h o uld be e ntere d i nt o t he C R F i n a n 
a gree d u p o n ti mefra me bet wee n t he I n vest i gat or a n d S p o ns or.  
G S K C H will o btai n a n d retai n all C R Fs a n d ass o ciate d st u d y data at t he c o mplet i on of  the 
st u d y. 
9. [ADDRESS_195615] u d y p erfor ma nce. 
A n y c ha n ges or c o rrecti o ns t o data will be p erf or me d i n t he El e ctr o nic Data Ca pt ure ( E D C) 
S y st e m, a n d it  will i ncl u de r atio nale f or c ha n ges. T he E D C s yste m has a n a u dit trail, w hic h 
will pr o vi de a c o m plete rec or d of t he c ha n ges a n d c orrecti o ns e n d orse d b y  t he I n vesti gat or.
A n y c orrectio ns t o t he e ntries ma de t o pa per s ource d oc u m e nts m ust be date d, i nitialle d, a n d 
e x plai ne d (if ne cessar y) a n d s h o uld n ot o bsc ure t he ori gi nal e ntr y . 
A d verse e ve nts will be c o de d usi n g Me d D R A ( M e dical Dict i onar y f or Re g ul at or y Act i vities) 
a n d c o nc o mit a nt me d icati ons t er ms (if a p plica ble) usi n g a n i nter nal vali date d me d icati on 
di ct i onar y , G S K Dr u g.  
9. 3. [ADDRESS_195616] i onar y D e v el o p m e nt a n d Ma na ge me nt 
Gr o u p will raise q ueries as nee de d o n safety d at a t o c o de t he t er ms ( Ad verse E ve nts a n d 
Dr u gs) a p pr o priatel y . 
T he st u d y mo ni t or at  the st u d y sit e will re vie w t he C R Fs i n acc or da nce wi t h the m o nit ori n g 
pl a n, a n d a n y q ueries will be ge nerate d i n t he E D C S y st e m to t he I n vesti gat or or desi g nee, 
e na bli n g t he err ors t o be a d dresse d i n parallel wi t h Data Ma na ge me nt re vie w. T h e st u d y 
m o nit or ca n als o r u n re p orts a n d listi n gs o n t he C R Fs, t o raise ma n ual q ueries as nee de d f or 
sit e clarificatio n or c orrecti o n.
9. 4 Pr o c e s si n g P ati e nt R e p ort e d O ut c o m e s
P ati e nt re p orte d o utc o m e ( P R O) data ma y be c o llecte d fr o m diar y car ds, q uesti o n n ai res, etc, 
a n d e ntere d i nto t he s p o ns or’s cli nical data ma na ge m e nt s yste m (D M S).  In i nsta nces w here  D oc u m e nt N a m e   
T y p e  V ersi o n  D oc u m e nt I d e ntifi er  Eff ecti v e D at e  
    
R e as o n F or Iss u e   
 
 
 
 
 
 
 
 
 
 
 
 
 [ADDRESS_195617]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 4 7 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195618] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: [ADDRESS_195619] t he pri vac y of  su bjects, n o Pers o nall y I de ntifia ble I nf or matio n ( PII) 
(incl u di n g t he s u bject's na me or i nitials or bi rt h d at e) is t o be rec or de d o n all P R O’s t hat will 
be f or war de d t o G S K C H.
All P R O s o urce data s h o uld be re vie we d b y t he st u d y staff/st u d y mo ni t or (as a p pr o priate) t o 
e ns ure t hat a n y p ot e ntial A Es re p orte d o n t hese d oc u me nts are re prese nte d i n t he D M S.
9. [ADDRESS_195620] a n d time p oi nt r efere nce d i n t he C R F a n d/ or 
pr ot oc ol . 
A n a gree d u p o n q ualit y c o ntrol pr ocess is perf or me d a gai nst t he tra nscri be d data t o t he s o urce 
t o e ns ure t he acc urac y of  the tra nscript i on. T he tra nscri be d d at a is tra ns mitte d i n a n a gree d 
u p o n f or m at t o G S K C H. 
Rec o nciliat i on will be p erf or m e d bet wee n t he tra nscri be d data a n d t he c li nical data base t o 
e ns ure s u bject a n d ti me p oi nt refere nce d i n t he Cli nical Data base mat c h bef ore Cli nical 
Data base Freeze (l oc ki n g of t he data base) ca n occ ur.
[ADDRESS_195621] u d y, n o f or mal sa m ple size 
calc ulat i on was c o n d ucte d.  
 
 
 
T heref ore, a p pr o xi matel y 4 8 ( ma xi m u m 5 0) heal t h y s u bjects wi t h bot h  ma xillar y a n d 
ma n di b ular f ull de nt ures will be e nr olle d i n t his st u d y.  S u bj e ct r e cr uit me nt will be c o ntr olle d 
t o e ns ure 5 0 ± 1 0 % of  the s u bjects will be i n eac h of  the l ow a n d hi g h Ka p ur -Ol s ha n gr o u ps 
[t he l ow Ka p ur -Ols ha n gr o u p is defi ne d as a c o mp osi t e Ka p ur -Ol s ha n sc ore of  6- 1 4 
(cli nicall y fair a n d g o o d de nt ures) a n d t he hi g h Ka p ur -Ols ha n sc ore as 1 5 - 1 8 (cli nicall y ver y 
g o o d de nt ures)].
[ADDRESS_195622] a n
A d dit i onal details of  the pr o p ose d statistical a nal ysis will be d o c u m e nte d i n t he statistical 
a na l ysis pla n ( S A P), w hic h will be wri tte n f oll owi n g fi nalisati on of  the pr ot oc ol  an d pri or t o 
st u d y u n bli n di n g / a nal ysis (as a p pr o priate). D oc u m e nt N a m e   
T y p e  V ersi o n  D oc u m e nt I d e ntifi er  Eff ecti v e D at e  
    
R e as o n F or Iss u e   
 
 
 
 
 
 
 
 
 
 
 
 
 [ADDRESS_195623]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 4 8 of 6 2C CI
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195624] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: 2 2-J u n-2 0 1 7
Pa ge 4 9 of  6 21 0. 2. 1 D efi niti o n of A n al y si s P o p ul ati o n s
 All assess me nts of safet y will be base d o n t he safet y  p o p ulatio n, defi ne d as all s u bjects 
w h o are ra n d o mise d a n d recei ve at least o ne d os e of  st u d y tr e at me nt d uri n g t he st u d y. 
S af et y p o p ul at i on s u m maries will be prese nte d b y  tr e at me nt recei ve d.
 T he pri mar y p o p ul at i on f or efficac y assess me nt will be t he i nte nt -t o-treat (I T T) 
p o p ul at i on, defi ne d as all s u bjects w h o are ra n d o mise d, recei ve t he st u d y treat me nt at 
least o nce a n d pr o vi de at least o ne assess me nt of efficac y.
 T he P P p o p ul at i on i ncl u des all s u bjects w h o f ull y c o m p l y wi t h all st u d y pr oce d ures 
a n d restricti o ns.
1 0. 2. 2 E x cl u si o n of D at a f r o m A n al y si s 
E xcl usi o n of  an y d at a fr om t he a nal yses will be deter mi ne d d uri n g a Bli n d D at a Re vie w 
Meet i n g pri or t o data base loc k. A n y reas o ns f or e xcl usi o n f r o m a n a nal ysis p o p ulat i on will be 
liste d, if a p plica ble.
T he Per Pr ot oc ol ( P P) p o p ulat i on will b e a s u bset of t he I T T p o p ulat i on. 
S u bjects wit h a pr ot oc ol vi o lati on t hat is dee me d t o affect efficac y f or all efficac y assess me nts 
will be e xclu de d fr o m t he P P p o p ul at i on. S u bjects wi t h a pr ot oc ol vi olati on t hat is dee me d t o 
affect efficac y for o nl y  so m e ( but n ot all) of  the efficac y assess me nts will be part of  the P P 
p o p ul at i on, b ut t heir data will be e xcl u de d fr o m t he assess me nt at w hic h t he pr ot oc ol vi olat i on 
occ urre d. A P P a nal ysis will be p erf or m e d o nl y if 1 0 % or m o re I T T s u bjects are e xcl u de d 
fr om P P p o p ul at i on. 
[ADDRESS_195625] atistics ( n u m ber of  su bjects, mea n, sta n dar d de viati o n, me dia n, mi ni m u m a n d 
ma xi m u m f or c o nt i n u o us v ari a bles, a n d fre q ue nc y a n d perce nta ge f or cate g orical varia bles) 
will be pr o vi de d f or d e m o gra p hic a n d baseli ne c haracteristics. Me dical hist or y  an d c urre nt 
me dical c o n dit i ons will be liste d.
1 0. 2. 4 Tr e at m e nt s ( st u d y dr u g/ pr o d u ct, r e s c u e m e di c ati o n, ot h er 
c o n c o mit a nt t h er a pi e s, c o m pli a n c e)
Pri or me d icati ons, c o nc o mit a nt me d icati ons a n d sig nifica nt n o n- dr u g t hera pi[INVESTIGATOR_167777] n d uri n g 
treat me nt will be liste d f or t he safety p o p ul at i on. C o m plia nce t o t he st u d y pr o d ucts will als o  
be s u m marise d.
1 0. 2. 5 Pri m ar y A n al y si s
F o o d occl usi o n  will be meas ure d b y wei g ht of  pea n ut parti cles ( mass of  retrie ve d pea n uts i n
gr a m s). Descri pti ve st atistics (Ra w mea ns, sta n dar d de viat i ons, sta n dar d err ors, mi ni m u m  a nd 
ma xi m u m val ues) of  c o m bi ne d masses of  pea n uts rec o vere d fr om ma n di b ular a n d ma xillar y 
de nt ures a n d t heir ass ociate d ga uzes will be pr o vi de d b y  tr e at me nt gr o u p. D oc u m e nt N a m e   
T y p e  V ersi o n  D oc u m e nt I d e ntifi er  Eff ecti v e D at e  
    
R e as o n F or Iss u e   
 
 
 
 
 
 
 
 
 
 
 
 
 [ADDRESS_195626]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 4 9 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195627] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: [ADDRESS_195628] or/ Scie nt ist or desi g nee pri or t o data base l oc k. Treat m e nt -e mer ge nt 
a d verse e ve nt ( Oral AEs as w ell as all A Es) will b e ass o ci at e d with t he m o st r e c e nt tr e at me nt 
recei ve d. T he n u m ber of A Es a n d n u m ber of s u bjects wit h AEs will be liste d a n d ta b ulate d b y 
treat me nt. T he res ults of O S T e xa ms will be liste d. I nci de nts will be liste d.
[ADDRESS_195629] atistics (Ra w mea ns, sta n dar d de viati ons, sta n dar d err ors, mi ni m u m a n d 
ma xi m u m v al ues) of  masses of  pea n uts rec o vere d fr om ma n di b ular, ma xillar y  an d c o m bi ne d 
de nt ures will be pr o vi de d b y treat me nt gr o u p.
Descri pt i ve st atistics (Ra w mea ns, sta n dar d de viat i ons, sta n dar d err ors, mi ni m u m a n d 
ma xi m u m val ues) of  c o m bi ne d masses of  pea n uts rec o vere d fr om ma n di b ular a n d ma xillar y 
de nt ures will be pr o vi de d b y tr e at me nt gr o u p i n l ow a n d hi g h Ka p ur -Ols ha n gr o u ps of 
s u bjects.
Descri pt i ve st atistics (Ra w mea ns, sta n dar d de viat i ons, sta n dar d err ors, mi ni m u m a n d 
ma xi m u m val ues) will als o be pr o vi de d f or t he n u m ber of de nt ure di slo d ge me nts b y treat me nt 
gr o u p. Mass of  pea n uts will als o be pl ott e d a gai nst t he n u m ber of  disl o d ge me nts o verall a n d 
b y tr e at me nt gr o u p.
F or t he s u bjects’ res p o nses t o q uesti o n n aires, descri pt i ve st atistics ( nu m ber of  su bjects a n d 
perce nta ges) will be pr o vi de d f or eac h q uesti o n b y treat me nt gr o u p.
1 0. 2. 8 A d diti o n al A n al y s e s
F or f ut ure de vel o p me nt w or k, a djuste d mea ns of  masses of  pea n uts rec o vere d fr om 
ma n di b ular, ma xillar y a n d c o m bi ne d de nt ures , al o n g wi t h 95 % c o nfi de nce i nter val will als o 
be re p orte d b y tr e at me nt gr o u p. T hese will be deri ve d fr om a mi xe d m o del wi t h perio d a n d 
treat me nt as fi xe d effects a n d s u bject as a r a n d o m effect. Treat me nt differe nces a n d 9 5 % 
c o nfi de nce i nter vals o f treat me nt differe nces will be re p orte d .
Usi n g t he sa me m o del as a b o ve, a s u b gr o u p a nal ysis will  be als o c o n d ucte d i n l ow a n d hi g h 
Ka p ur -Ols ha n gr o u ps of  su bjects . A d j uste d mea ns of  c o m bi ne d masses of  pea n uts rec o vere d 
fr om ma n di b ular a n d ma xillar y de nt ur e, alo n g wi t h 95 % c o nfi de nce i nter val will b e re p orte d 
b y treat me nt gr o u p s f or eac h s u b-gr o u p.
T hese res ults will be re p orte d i n t he statistical a p pe n di x as part of t he C S R.
[ADDRESS_195630]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 5 0 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195631] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: [ADDRESS_195632] u d y.
1 1 S T U D Y G O V E R N A N C E C O N SI D E R A TI O N S
1 1. 1 Q u alit y C o ntr ol 
I n acc or da nce wi t h a p plica ble re g ulati ons i ncl u di n g G C P, a n d G S K pr oce d ures, G S K or 
desi g nee (i.e. t hir d part y  ve n d or) mo ni t ors will c o ntact t he sit e prior t o t he start of t he st u d y  t o 
re vie w wi t h t he sit e staff t he pr ot o c ol , st u d y re q uire me nts, a n d t heir res p o nsi bilities t o s atisf y 
re g ulat or y, et hical, a n d G S K re q uire me nts.
W he n re vie wi n g data c ollecti o n pr oce d ures, t he disc ussi o n will i ncl u de i de ntificati on, 
a gree me nt a n d d oc u me ntati o n of  data ite ms f or w hic h t he C R F will ser ve as t he s o urce 
d oc u m e nt.
G S K or desi g nee will m o nit or t he st u d y  a n d site acti vit y t o verif y t hat t he:
 Data are a ut he ntic, acc urate, a n d c o m plete.
 S af et y a n d rig hts of  s u bjects are bei n g pr otecte d.
 St u d y  is c o n d ucte d i n acc or da nce wi t h the c urre ntl y a p pr o ve d pr ot oc ol  an d a n y ot h er 
st u d y a gree me nts, G C P, a n d all a p plica ble re g ulat or y r e q uire me nts.
T he e xte nt a n d nat ure of  mo ni t ori n g will  be descri be d i n a wri tte n m o nit ori n g pl a n o n file at 
G S K C H. T he i n vesti gat or ( or desi g nee) a grees t o all o w t he m o nit or direct access t o all 
r ele va nt d oc u m e nts a n d a grees t o c o -o perate wit h t he m o nit or t o e ns ure t hat a n y pr o bl e ms 
detecte d i n t he c o urse of t hese m o nit ori n g visit s are res ol ve d.
[ADDRESS_195633] a q ualit y ass ura nce assess me nt a n d/ or a u dit of  the sit e rec or ds, a n d t he re g ulat or y 
a ge ncies ma y c o n d uct a re g ulat or y ins pect i on at a n y time d uri n g or aft er c o mpleti o n of  the 
st u d y. 
I n t he e ve nt of a n assess me nt, a u dit or i ns pectio n, t he i n vest i gat or (a n d i nstituti o n) m ust a gree 
t o gra nt t he a d vis or(s), a u dit or(s) a n d i ns pect or(s) direct access t o all rele va nt d oc u m e nts a n d 
t o all ocate t heir time a n d t he time of  their staff t o disc uss t he c o n d uct of  the st u d y, a n y 
fi n di n gs/rele va nt iss ues a n d t o i m ple me nt a n y c orrecti ve a n d/ or pre ve ntati ve a ctio ns t o 
a d dress a n y fi n di n gs/iss ues i de ntifie d.
T he i n vest i gat or(s) will n otif y G S K C H or its a ge nts i m me diatel y of a n y re g ulat or y ins pecti o n 
n otificati o n i n relati on t o t he st u d y. F urt her m or e, t he i n vesti gat or will c o o perate wit h G S K 
C H or its a ge nts t o pre pare t he st u d y sit e f or t he i ns pecti on a n d will allo w G S K C H or its 
a ge nt, w he ne ver feasi ble, t o be prese nt d uri n g t he i ns pecti on. T he i n vesti gat or will pr o m pt l y 
a p pl y c o pi[INVESTIGATOR_1309] t he i ns pecti o n fi n di n g t o G S K C H or its a g e nt. B efore res p o nse s u b missi o n  t o  D
oc u m e nt N a m e   
T y p e  V ersi o n  D oc u m e nt I d e ntifi er  Eff ecti v e D at e  
    
R e as o n F or Iss u e   
 
 
 
 
 
 
 
 
 
 
 
 
 [ADDRESS_195634]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 5 1 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195635] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: [ADDRESS_195636] u d y as p er 2 1 C F R 
8 1 2. 2(c)( 1) a n d 2 1 C F R 8 1 2. 2(c)( 4). T hi s st u d y d o es not r e q ui re re g ulat or y a p pr o val pri or t o 
c o n d ucti n g t he st u d y.
[ADDRESS_195637] u d y pr ot oc ol , 
pr ot oc ol  a me n d me nts, i nf or me d c o nse nt d oc u m e nts, safet y state me nt (incl u di n g a n y u p dates) 
a n d ot h er r ele va nt d oc u me nts, e. g., recr uit me nt a d vert ise me nts, if a p plica ble, fr om t he I R B.  
All c orres p o n de nce wi t h the I R B s h o uld be retai ne d i n t he i n vesti gat or file.  Co pi [INVESTIGATOR_1309] I R B 
a p pr o vals s h o uld be f or war de d t o G S K C H pri or t o t h e i nitiati on of t he st u d y, a nd als o w he n 
s u bse q ue nt a me n d me nts t o t he pr ot oc ol are ma de.
T he o nl y circ u msta nce i n w hic h a n a me n d me nt ma y be i nit iate d pri or t o I R B a p pr o val is 
w here t he c ha n ge is necessar y  t o eli mi nate a p pare nt i m me diate hazar ds t o t he s u bjects.  I n t hat 
e ve nt, t he i n vesti gat or m ust n otif y t he I R B a n d G S K C H i n wri tin g i m me diatel y aft er t he 
i m ple me ntati o n.
[ADDRESS_195638] u d y will be c o n d ucte d i n acc or da nce wi t h le g al a nd re g ulat or y re q uire me nts, as well as 
t he ge neral  princi ples set f ort h in t he I nt er n atio nal Et hical G ui deli nes f or Bi o m e dical 
Researc h I n v ol vi n g H u ma n S u bjects ( C o u ncil f or I nter nati o nal Or ga nizat i ons of  Me dical 
S ci e nces 2 0 0 2), g ui deli nes f or G C P ((I C H, 1 9 9 6 ) a n d re visi on 2), a n d t he Declarat i on of 
Helsi n ki ( (W o rld Me dical Ass oci at io n, 2 0 0 8 )). 
I n a d diti on, t he st u d y  will be c o n d ucte d i n acc or da nce wit h t he pr ot oc ol, t he I C H g ui deli ne o n 
G C P, a n d a p plica ble l ocal re g ulat or y  r e q uire me nts a n d la ws.
[ADDRESS_195639]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 5 2 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195640] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: [ADDRESS_195641]’s n u merical c o de t o his or her act ual i de ntity.   In case of  data tra nsfer, 
G S K C H will mai ntai n hi g h sta n dar ds of  co nfi de nt iality a n d pr otecti o n of  su bjects’ pers o nal 
data c o nsiste nt wit h a p plica ble pri vac y la ws.
T he i nf or me d c o nse nt d oc u m e nts m u st be i n c o m plia nce wi t h IC H G C P, l ocal re g ulat or y 
re q uire me nts, a n d le gal re q uire me nts, i ncl u di n g a p plica ble pri vac y la ws.
T he i nf or me d c o nse nt d oc u me nts use d d uri n g t he i nf or me d c o nse nt pr ocess m ust be re vie we d 
a n d a p pr o ve d b y t he s p o ns or, a p pr o ve d b y t he I R B/ E C bef ore use, a n d a vaila ble f or 
i ns pecti o n.
T he i n vesti gat or m u st e ns ure t hat eac h st u d y su bject, is full y i nf or me d a b o ut t he nat ure a n d 
o bj ect i ves of t he st u d y a n d p ossi ble ris ks ass ociate d wit h partici pati on. 
T he i n vesti gat or, or a pers o n de sig nate d b y t he i n vesti gat or, will o btai n wri tte n i nf or me d 
c o nse nt fr o m eac h s u bject bef ore a n y st u d y-s pecific acti vit y is p erf or m e d.  The i n vesti gat or 
will retai n t he ori gi nal o f eac h s u bject's si g ne d i nf o r me d c o nse nt d oc u me nt.
[ADDRESS_195642] u d y is allo we d. T his ge neric 
q uesti o n naire ma y be use d b y sit es as a p h o ne s cript a n d/ or t o re vie w i nter nal data bases t o 
i de ntif y s u bjects.  
G S K C H will ha ve a n o p p ort u ni t y t o re vie w a n d a p pr o ve t he c o nte nt of a n y st u d y recr uit me nt 
materi als directe d t o p ote ntial st u d y s u bjects bef ore s uc h materials are use d. 
[ADDRESS_195643] i on i m p ose d (i.e., cli nical h o l d) b y a n a p plica ble 
c o mpete nt a ut h orit y in a n y area of  the w orl d, or if t he in vest i gat or is aware of  an y ne w 
i nf or mat i on t hat mi g ht i nfl ue nce t he e val uati on of  t he be nefits a nd ris ks of  t he i n vesti gati onal 
pr o d uct, G S K C H s h o ul d be i nf or me d i m me diatel y. 
I n a d ditio n , t he i n vesti gat or will i nf or m G S K C H i m me diatel y of  a n y ur ge nt safet y meas ures 
ta ke n b y t he i n vesti gat or t o pr otect t he st u d y su bjects a gai nst a n y i m me diate hazar d, a n d of  
a n y seri o us breac hes of t his pr ot oc ol or of I C H G C P t hat t he i n vest i gat or bec o mes a ware of. D oc u m e nt N a m e   
T y p e  V ersi o n  D oc u m e nt I d e ntifi er  Eff ecti v e D at e  
    
R e as o n F or Iss u e   
 
 
 
 
 
 
 
 
 
 
 
 
 [ADDRESS_195644]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 5 3 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195645] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: [ADDRESS_195646] u d y rec or ds (e xce pt 
f or t hose re q uir e d b y l ocal re g ulati ons t o be mai ntai ne d else w here), i n a s afe a n d sec ure 
l ocat i on.  
T he rec or ds (st u d y/ sit e master file) m ust be mai ntai ne d t o all o w eas y a n d timel y r etrie val, 
w he n nee de d (e. g., f or a G S K a u di t or r e g ulat or y i ns pect i on) a n d m ust be a vaila ble f or re vie w 
i n c o nju n cti o n wi t h assess me nt of t he facilit y, s u p p orti n g s yste ms, a n d rele va nt site staff.
W here per mi tt e d b y l ocal la ws/re g ulati o ns or i nstit uti o nal p olic y, s o me or all of t h es e r e c or ds 
ca n be mai ntai ne d i n a f or mat ot h er t ha n har d c o p y (e. g., micr ofic he, sca n ne d, electr o nic); 
h o we ver, ca ut i on nee ds t o be e xercise d bef ore s uc h act i on is ta ke n. 
T he i n vesti gat or m ust e ns ure t hat all re pr o d uctio ns are le gi ble a n d are a tr ue a n d acc urate 
c o p y of t he ori gi nal a n d meet accessi bilit y a n d r etrie val sta n dar ds, i ncl u di n g r e-ge nerat i n g a 
har d c o p y , if re q uir e d.  F urt h er mor e, t h e i n vesti gat or must e ns ure t here is a n acce pta ble bac k -
u p of  these re pr o d uctio ns a n d t hat a n acce pta ble q ualit y c o ntr ol pr ocess e xists f or ma ki n g 
t hese re pr o d ucti o ns.
T he i n vesti gat or m ust ass ure t hat t he s u bject’s a n o n y mit y will be mai ntai ne d.  On C R Fs or 
ot her d oc u me nts s u b mitte d t o G S K C H, s u bjects s h o uld n ot be i de ntifie d b y t heir na mes or 
i nitials, b ut b y a n i de ntificati on c o de. T he i n vesti gat or s h o uld k e e p a se parate l og of  su bjects’ 
c o des, na mes a n d a d dresses.  Do c u m e nts n o t f or s u b missi on t o G S K C H, e. g. s u bjects’ 
wri tte n c o nse nt f or ms, s h o ul d be mai ntai ne d b y t he i n vesti gat or i n strict c o nfi de nce. D oc u m e nt N a m e   
T y p e  V ersi o n  D oc u m e nt I d e ntifi er  Eff ecti v e D at e  
    
R e as o n F or Iss u e   
 
 
 
 
 
 
 
 
 
 
 
 
 [ADDRESS_195647]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 5 4 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195648] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: [ADDRESS_195649] u d y Re p ort 
( C S R)/ e q ui vale nt s u m mar y u nless l ocal re g ulati ons or i nstituti o nal  pol icies re q uire a l on ger 
rete ntio n p eri o d. T he mi ni m u m rete ntio n ti me will meet t he strictest sta n dar d a p plica ble t o 
t hat sit e f or t he st u d y, as dictate d b y a n y insti t utio nal re q uire me nts or l ocal la ws or 
re g ulat i ons, G S K sta n dar ds/ pr oce d ures, a n d/ or i nstit ut i onal re q uire me nts.  
N o stu d y d o c u m e nt s h o uld be destr o ye d wi t ho ut a  prior wri tte n a gree me nt bet wee n G S K C H 
a n d t he i n vesti gat or. T he i n vesti gat or m ust n otif y G S K of  an y c ha n ges i n t he arc hi val 
arra n ge me nts, i ncl u di n g, b ut n ot li mite d t o, arc hi val at a n off -sit e facilit y or tra nsfer of 
o w ners hi p of t he rec or ds i n t he e ve nt t he i n vesti gat or is n o l o n ger ass ociate d wit h t he site.
[ADDRESS_195650] u d y ma y occ ur beca use of  a re g ulat or y aut h ori t y decisio n , 
c ha n ge i n o pi [INVESTIGATOR_9384] o n  of t he I R B/ E C, or i n vesti gati o nal pr o d uct safety pr o bl e ms, or at t he 
di scretio n of  GS K  CH.  I n ad di tio n , G S K C H retai ns t he rig ht t o disc o nti n ue d e v el o p m e nt of  
de nt ure a d hesi ves at a n y  ti me.  
If a st u d y is pre mat urel y  ter mi nate d, G S K C H will pr o m pt l y n otif y t he i n vesti gat or.  After 
n otificati o n, t he i n vesti gat or m u st pr o m pt l y c o ntact all partici pati n g s u bjects a nd s h o uld 
ass ure a p pr o priate t hera p y/ f oll o w- u p f or t he s u bjects.  As directe d b y G S K C H, all st u d y 
materi als m ust be c o llecte d a n d all C R Fs c o m p lete d t o t he greatest e xte nt p ossi ble. W here 
re q uire d b y t he a p plica ble re g ulat or y re q uire me nts, G S K C H s h o uld i nf or m  the re g ulat or y 
a ut h orit y(ies) a n d t h e i n vesti gat or s h o uld pr o m pt l y i nf or m t h e I R B a n d pr o vid e t h e I R B/ E C a 
detaile d writte n e x pla nat i on of t he ter mi nat i on or s us pe nsi o n. 
If t he I R B/ E C ter mi nates or s us pe n ds its a p pr o val/fa v o ura ble o pi [INVESTIGATOR_9384] o n  of a trial, t he 
i n vesti gat or s h o uld pr o m pt l y n otif y t he G S K C H a n d pr o vi de G S K C H wi t h a detaile d writte n 
e x pla nat i on of t he ter mi nat i on or s us pe nsi o n.
U p o n c o mplet i on or pr e m at ure di sc o nti n uati on of  the st u d y, t he G S K C H m o nit or will 
c o n d uct sit e clos ure acti vit ies wi t h t he i n vesti gat or or sit e staff, as a p pr o priate, i n acc or da nce 
wi t h a p plica ble re g ulati ons i ncl u di n g G C P, a n d G S K C H Sta n dar d O perati n g Pr oce d ures.
[ADDRESS_195651] u d y E n d/ E n d of St u d y 
T he e n d of t he st u d y  will be t he date of t he Last S u bject Last Vi sit ( L S L V).  F or t his st u d y t h e 
L S L V date will be t he pri mar y c o m p leti o n date ( P C D).
[ADDRESS_195652] u d y  to E val uate t he A bilit y of  an 
E x peri me ntal De nt ure A d hesi ve t o Pre ve nt F o o d P arti cle I ngress u n der De nt ures. G S K Data 
H el d o n File; [ADDRESS_195653] of  De nt ure 
A d hesi ve o n F o o d Occl usi o n. Mala ysia n De nt. J. 2 0 0 9; 3 0( 2): [ADDRESS_195654]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 5 5 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195655] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: [ADDRESS_195656] of  De nt ure A d hesi ves i n Li mit i n g t he F o o d I mp a cti o n. Mala ysia n De nt. J. 
2 0 1 0; 3 1( 2): 6 5 - 7 0.
F D A U. G ui da nce f or I n d ustr y: C o llecti on of  Race a n d Et h nicit y D at a i n Cli nical Tri als. 
[ADDRESS_195657] ice C p m p/Ic h/ 1 3 5/ [ADDRESS_195658] het. De nt. 1 9 6 7; 1 8( 6): 5 5 0- 8.
 
 
 
 
M u n oz -Vi ver os C, Sc h o ber N, Ca m pi[INVESTIGATOR_4382] o M, G o nser F, S ha n ga G, Ma g n usze ws ki T, et al. 
De nt ure A d hesi ve Re d uce d F o o d E ntra p m e nt u n der Re m o v a ble P arti al De nt ures. J. De nt. 
Res. 2 0 1 0; 9 0( S pec Iss A): A bstract 1 0 5 3.
M u n oz -Vi ver os C, T ys o n -J o h ns o n D, Fer na n dez P, Ca m pi[INVESTIGATOR_4382] o M, S ha n ga G, Ge n drea u L, et al. 
De nt ure A d hesi ve Re d uce d F o o d E ntra p m e nt u n der Re m o va ble F ull De nt ures. J. De nt. Res. 
2 0 1 0; 9 0( S pec Iss A): A b stract [ADDRESS_195659] u d y  to E val uate De nt ure A d hesi ve Use i n Well   Fi tti n g De nt ures. J. Pr ost h o d o nt. 
2 0 1 2; 2 1( 2): 1 2 3 - 9.
Ol s ha n A, R oss N, Ma n k o di S, Melita S. A M o difie d Ka p ur Scal e f or E val uat i n g De nt ure 
Rete nti o n a n d Sta bilit y: Met h o d ol o g y  St u d y. A m. J. De nt. 1 9 9 2; 5( 2): [ADDRESS_195660] h o d o nt. 2 0 0 5; 1 4( 2): 1 2 2 -6.
 
S al da n ha S, S h e n o y V K, Eac ha m pat i P, U p pal N. De ntal  Im p licati ons of  
Bis p h o p h o nate   Rel ate d Oste o necr osis. Ger o do nt ol o g y . 2 0 1 2; 2 9( 3): [ADDRESS_195661]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 5 6 of 6 2C CI
C CI
C CI
C CI
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195662] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: [ADDRESS_195663] het. De nt. 1 9 8 0; 4 4( 4): [ADDRESS_195664] of a b bre viat i ons t hat m a y be use d i n t he pr ot oc ol.
T a bl e 1 3 - 1 A b br e vi ati o n
A b br e vi ati o n T er m
° C D e gr e e C e nti gr a d e
° F D e gr e e F a hr e n h eit
A E A d v er s e E v e nt
A N O V A A n al y si s of V ari a n c e
CI C o nfi d e n c e I nt er v al
C R F C a s e R e p ort F or m
C S A Cli ni c al St u d y A gr e e m e nt
C T A Cli ni c al Tri al A p pli c ati o n
e C R F El e ctr o ni c C a s e R e p ort F or m
E u dr a C T E ur o p e a n Cli ni c al Tri al s D at a b a s e
F D A F o o d a n d Dr u g A d mi ni str ati o n ( U nit e d St at e s)
F D A A A F o o d a n d Dr u g A d mi ni str ati o n A m e n d m e nt s A ct ( U nit e d St at e s)
g Gr a m
G C P G o o d Cli ni c al Pr a cti c e
G S K Gl a x o S mit h Kli n e
G S K C H Gl a x o S mit h Kli n e C o n s u m er H e alt h c ar e
I C H I nt er n ati o n al C o nf er e n c e o n H ar m o ni s ati o n
I R B I n stit uti o n al R e vi e w B o ar d
L S L V L a st S u bj e ct L a st Vi sit 
M e d D R A M e di c al Di cti o n ar y f or R e g ul at or y A cti viti e s
N/ A N ot A p pli c a bl e
O S T Or al S oft Ti s s u e
PI [INVESTIGATOR_120201] n ci p al I n v e sti g at or
S A E S eri o u s A d v er s e E v e nt
S O P St a n d ar d O p er ati n g Pr o c e d ur e
S S S af et y St at e m e nt
U S U nit e d St at e s D oc u m e nt N a m e   
T y p e  V ersi o n  D oc u m e nt I d e ntifi er  Eff ecti v e D at e  
    
R e as o n F or Iss u e   
 
 
 
 
 
 
 
 
 
 
 
 
 [ADDRESS_195665]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 5 7 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195666] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: [ADDRESS_195667]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 5 8 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195668] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: [ADDRESS_195669] i ons 2 -4 if y o u ci rcle d “ Yes” f or q uestio n 1 a b o ve.
1 2 3 4 5 6 7 8 9 1 02 ) O n a s c al e of 1 t o 1 0 h o w w o ul d y o u r at e t h e a m o u nt of p e a n ut p arti cl e s t h at w e nt 
u n d er y o ur d e nt ur e ? ( Pl e a s e cir cl e y o ur a n s w er) 
N o n e N u m er o u s
1 2 3 4 5 6 7 8 9 1 03 ) O n a s c al e of 1 t o 1 0 h o w w o ul d y o u r at e t h e irrit ati o n of p e a n ut s u n d er y o ur 
d e nt ur e ? ( Pl e a s e cir cl e y o ur a n s w er) 
N ot at all Irrit ati n g E xtr e m el y Irrit ati n g
1 2 3 4 5 6 7 8 9 1 04 ) O n a s c al e of 1 t o 1 0 h o w b ot h er e d w er e y o u b y t h e p e a n ut s t h at w e nt u n d er y o ur 
d e nt ur e ? ( Pl e a s e cir cl e y o ur a n s w er) 
N ot at all B ot h er e d E xtr e m el y B ot h er e d1) W er e y o u a w ar e of p e a n ut s u n d er y o ur d e nt ur e ? ( Pl e a s e cir cl e y o ur a n s w er) 
Ye s N o D oc u m e nt N a m e   
T y p e  V ersi o n  D oc u m e nt I d e ntifi er  Eff ecti v e D at e  
    
R e as o n F or Iss u e   
 
 
 
 
 
 
 
 
 
 
 
 
 [ADDRESS_195670]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 5 9 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195671] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: [ADDRESS_195672] A p pli c ati o n I n str u cti o n s
Ra n d o misat i on C o de [   ]
F or a p plicat i on per c o n ve nt i onal patter n ….
1. E xtr u de a n d dis p ose of first [ADDRESS_195673] 
c o nsiste nc y.
2. Pre -l oa d 2 s yrin ges wi t h 1. 0 0 ± 0. 0 5 g a n d 0. 6 0 ± 0. [ADDRESS_195674] via t he pre - wei g he d s yri n ge i n s h ort stri ps as s h o w n i n t he dia gra m, n ot 
t o o cl ose t o t he de nt ure e d ges ( 3 stri ps s h o ul d be a p plie d t o t he u p per de nt ure a n d 2 o n 
t he lo wer de nt ure).  All of t he a d hesi ve i n t he pre -w ei g he d s yri n ge s h o ul d be use d.
5. Ha ve t he s u bject ri nse t heir m o ut h wit h water a n d e x pect orate bef ore i nserti n g t he 
de nt ures.
6. Ha ve t he s u bject press de nt ures i nt o pla c e fir ml y, a n d bite d o w n f or a fe w sec o n ds t o 
sec ure h ol d. D oc u m e nt N a m e   
T y p e  V ersi o n  D oc u m e nt I d e ntifi er  Eff ecti v e D at e  
    
R e as o n F or Iss u e   
 
 
 
 
 
 
 
 
 
 
 
 
 [ADDRESS_195675]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 6 0 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195676] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: 2 2-J u n-2 0 1 7
Pa ge 6 1 of  6 2Ra n d o misat i on C o de [   ]
F or a p plicat i on per c o nti n u o us stri ps patter n ….
1. E xtr u de a n d dis p ose of first [ADDRESS_195677] 
c o nsiste nc y.
2. Pre -l oa d 2 s yrin g es wit h 1. 0 0 ± 0. 0 5 g a n d 0. 6 0 ± 0. [ADDRESS_195678] via a pre -w ei g he d s y rin ge i n l o n g, c o nti n u o us stri ps as s h o w n i n t he 
di a gra m, n ot t o o close t o t he de nt ure e d ges ( 3 stri ps s h o ul d be a p plie d t o t he u p per 
de nt ure a n d 1 o n t he l o wer de nt ure).  All o f t he a d hesi ve i n t he pre -w ei g he d s yri n ge 
s h o uld be use d.
5. Ha ve t he s u bject ri nse t heir m o ut h wit h water a n d e x pect orate bef ore i nserti n g t he 
de nt ures.
6. Ha ve t he s u bject press de nt ures i nt o place fir ml y, a n d bite d o w n f or a fe w sec o n ds t o 
sec ure h ol d. D oc u m e nt N a m e   
T y p e  V ersi o n  D oc u m e nt I d e ntifi er  Eff ecti v e D at e  
    
R e as o n F or Iss u e   
 
 
 
 
 
 
 
 
 
 
 
 
 [ADDRESS_195679]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 6 1 of 6 2
S o di u m -calci u m mi xe d partial salt of p ol y( met h yl vi n y let her/ maleic aci d) a n d car b o x y met h ylcell ul ose
[ADDRESS_195680] 2 0 1 7
Gla x o S mit h Kli ne C o ns u mer Healt hcare C o nfi de ntial
Te m plate Ver si o n Effecti ve: 2 2-J u n-2 0 1 7
Pa ge 6 2 of  6 2Ra n d o misat i on C o de [   ]
F or a p plicat i on of n o a d hesi ve ….
1. Cl ea n a n d dr y de nt ures.
2. Ha ve t he s u bject ri nse t heir m o ut h wit h water a n d e x pect orate bef ore i nserti n g t he 
de nt ures.
3. Ha ve t he s u bject press de nt ures i nt o place fir ml y, a n d bite d o w n f or a fe w sec o n ds t o 
sec ure h ol d. D oc u m e nt N a m e   
T y p e  V ersi o n  D oc u m e nt I d e ntifi er  Eff ecti v e D at e  
    
R e as o n F or Iss u e   
 
 
 
 
 
 
 
 
 
 
 
 
 [ADDRESS_195681]- 2 0 1 7 0 8: 4 9: 0 5
 2 0 8 3 9 7 Cli ni c al Pr ot o c ol 2. d o c x
el d o _ c o ntr oll e d 2. 0; M o st- R e c e nt; Eff e cti v e; C U R R E N T
A ut o I s s u e0 9 0 0 3 2 d 5 8 0 d b 1 b 9 1
Pa ge 6 2 of 6 2
Sodium -calcium mixed partial salt of poly(meth ylvinylether/maleic acid) and carboxymethylcellulose
208397
Final Clinica l Protocol, 20 Oct2017
GlaxoSmithKline Consumer Healthcare Confidential
Template Version Effective: [ADDRESS_195682] the privacy of subjects, no Personally Identifiable Informati on (PII) 
(including the subject's name [CONTACT_167778]) is to be recorded on all PRO’s that will 
be forwarded to [COMPANY_004] CH .
All PRO source data shoul d be reviewed by [CONTACT_39802]/study  monitor (as appropriate) to 
ensure that any  potenti al AEs reported on these documents are represented in the DMS.
9.[ADDRESS_195683] and time point referenced in the CRF and/or 
protocol . 
An agreed upon qualit y contr ol process is performed against the transcribed data to the source 
to ensure the accuracy of the transcri ption. The transcribed data is transmitted in an agreed 
upon form at to [COMPANY_004] CH. 
Reconciliat ion will be performed between the transcribed data and the clinical database to 
ensure subject and time point referenced in the Clinical Database match before Clinical 
Database Freeze (locking of the database) can occur.
10 STATISTICAL CONSIDERATIONS AND DATA ANALYSES
10.1 Sample Size Determination
Since this is an exploratory methodol ogy development study , no formal sample size 
calculat ion was conducted.  
 
 
 
Therefore, approximately 48(maximum 50) healthy subjects with both maxillary and 
mandibular full dentures will be enrolled in this study .  Subject recrui tment will be controlled 
to ensure 50±10% of the subjects will be in each of the low and high Kapur -Olshan groups 
[the low Kapur -Olshan group is defined as a composite Kapur -Olshan score of 6-14 
(clinically fair and good dentures) and the high Kapur -Olshan score as 15-18 (clinically very 
good dentures)].
10.[ADDRESS_195684] ical analysis will be docum ented in the statistical 
analysis plan (SAP), which will be written following finalisat ion of the protocol  and prior to 
study  un
blinding / analysis (as appropriate).
Page [ADDRESS_195685]-2017 08:49:05208397 Clinical Protocol 2.docx
eldo_controlled 2.0; Most-Recent; Effective; CURRENT
Auto Issue090032d580db1b91
CCI